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Jefferson joined the Philadelphia 
skyline on October 20, 2019. 
Jefferson Center, previously 
Aramark, will be the new home 
for many Jefferson Health and 
Thomas Jefferson University 
services.
6   Jefferson.edu/Bulletin
Dean’s Column
An Acquired Taste
Mergers and acquisitions. It sounds 
more like a topic for MBAs than 
MDs. Yet the growing trend across 
the country is for health systems to 
merge with, acquire, or be acquired 
by other health systems. It’s the 
business of medicine and the wave 
of the future. Jefferson—so often 
ahead of the curve—has been riding 
the crest of that wave for the past 
five years.
From our acquisitions of other 
health systems in the Greater 
Philadelphia region and across the 
river in New Jersey to our merger 
with Philadelphia University, we have 
kept an eye on the rapidly changing, 
quickly evolving healthcare and 
education landscapes. For our 
academic medical center, the 
overarching goal is to provide an 
unparalleled education for the next 
generation of physicians, as we 
deliver the best patient care and 
conduct the most groundbreaking 
research.
Over the past two decades, health 
system consolidation has gained 
traction as larger entities purchase 
or merge with smaller ones, creating 
a win-win-win situation for patients, 
hospitals, and staff. Patients benefit 
from wider access to specialty and 
subspecialty services, clinical trials, 
and world-class physicians. Hospitals 
benefit from increased efficiency and 
cost savings through economies of 
scale—such as the consolidation of 
administrative services, personnel, 
laboratories, clinical services, and 
technology—as well as better 
access to resources for research and 
programs, and investment dollars 
to upgrade services at acquired 
hospitals. Healthcare professionals 
benefit through shareable electronic 
records, more coordinated patient 
care across the continuum, 
deployment and recruitment of 
additional medical staff to the 
acquired hospitals, and greater 
educational opportunities.
In 2018, Definitive Healthcare, which 
collects and analyzes industry trends 
in the U.S., identified 803 mergers 
and acquisitions and 858 affiliation 
and partnership announcements. 
Industry experts expect that trend to 
accelerate over the next few years; 
in 2014, Deloitte predicted that only 
half of the health systems operating 
that year would remain independent 
by 2024. This shift is happening 
with the approval of both physicians 
(a 2016 Deloitte survey found that 
53% of physicians would consider 
merging with a larger healthcare 
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organization) and patients (a recent 
PricewaterhouseCoopers Health 
Research Institute survey reports 
that 58% of consumers are likely to 
choose a community hospital that is 
affiliated with an academic medical 
center). 
While Jefferson is following that 
merger-and-acquisition trend, we 
are also going one step further 
to shape how that movement 
progresses.
Since 2015, Jefferson has been 
expanding in both size and reach 
across the Delaware Valley. We are 
moving and shaking the worlds of 
medicine and education, disrupting 
the field of healthcare as we know 
it in order to create one that is even 
better.
Over the past five years, we have 
acquired Abington Health (2015); 
Aria Health (2016); Kennedy Health 
in New Jersey (2016); and Magee 
Rehabilitation Hospital (2018). All 
told, Jefferson Health now has 
more than 30,000 employees and 
is the second-largest employer in 
Philadelphia. Yet others are now in 
play, as we are always looking for 
the next dynamic partnership to 
add value to our institution and our 
mission of improving lives.
These mergers and acquisitions 
have all been accomplished while 
maintaining a strong balance sheet. 
We are one of the fastest-growing 
health systems in the nation, yet 
while others have had to make 
drastic cuts, or have seen their bond 
ratings fall, we have more than 
doubled our operating revenue, and 
have kept our Standard & Poor’s  
rating intact with a solid A. That 
strong rating, along with financial 
stability, reinforces our long-term 
strategy to move forward as a 
leading, value-based healthcare 
system. Additionally, it has gained 
us international recognition as an 
ecosystem for higher education and 
innovation—because health isn’t all 
we do anymore. 
Never an institution that is content 
with the status quo, Jefferson forms 
associations that transcend the 
boundaries of medicine and medical 
education. In 2017, we merged with 
Philadelphia University, adding its 
world-class professional education 
to Jefferson’s own, creating the 
opportunity to combine our health 
and science expertise with their 
nationally ranked programs in areas 
such as design, fashion, textiles, and 
architecture. 
The idea behind our 
Medicine+Design program is to 
infuse more creativity into the way 
we care for patients by bringing 
a human-centered, design-
thinking perspective to healthcare, 
generating innovative solutions 
to the challenges caregivers and 
their patients face every day. Within 
that program, second-year SKMC 
students have been teaming up, in 
four-member teams, with students 
from our East Falls campus to 
first identify clinical challenges 
to be solved and then solve them 
with design-based solutions. 
The creativity manifest in these 
JeffSolves projects has been nothing 
short of inspiring, generating a flow 
of biotech start-up concepts.
For example, earlier this year, a 
team of SKMC medical students 
and Kanbar College of Design, 
Engineering, and Commerce 
industrial design students decided 
to rethink the anesthesia face 
mask, with an ingenious design 
that mitigates the risk of escaping 
anesthesia gas in the operating 
theatre. Another student team, 
including one with textiles expertise, 
devised an elegant headband with 
multifunction textile layers that 
comfortably protect neonates in 
intensive care units from ambient 
noise. Other projects over the 
past few years have been equally 
far-ranging—from a fundamental 
redesign of the standard urinalysis 
cup to reduce bacterial cross-
contamination of urine culture 
samples, to better layouts for 
emergency department and hospital 
rooms coming from teams of 
architecture and medical students. 
We do not live in a world that is 
neatly compartmentalized—that 
is why Jefferson’s Innovation 
Pillar exists. It brings together 
scientists, clinicians, researchers, 
businesspeople, entrepreneurs, 
and inventors to create tomorrow’s 
solutions for today’s problems. 
It encourages collaboration with 
companies to create and manage the 
production and commercialization 
of inventions and discoveries. And it 
allows for the leaders of the future 
to explore the fields of medicine, 
design, architecture, engineering, 
and the like. This is something 
uniquely Jefferson; we consider it an 
obligation to serve as a bellwether 
for the future of healthcare and 
medical education.
At Jefferson, we are broadening 
the training of the next generation 
of healthcare providers, as well as 
allowing opportunities for cross-
education in nonmedical fields to 
create more worldly professionals 
with the ability to become global 
thinkers. When worlds collide, great 
ideas are born. Jefferson increasingly 
sees itself as the academic and 
healthcare equivalent of the Big 
Bang—expanding horizons that 
nurture great ideas to make the 
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Sidney and Caroline Kimmel have 
once again championed Thomas 
Jefferson University’s mission to 
improve lives with a $70 million gift 
to establish the Caroline Kimmel 
Biomedical Research Building. The 
new Locust Street facility will provide 
Jefferson scientists with leading-
edge technology and laboratories, 
and will significantly advance medical 
research at Jefferson. 
“This gift will have a profound 
and lasting impact on Jefferson’s 
ability to further pursue scientific 
discovery,” says Mark L. Tykocinski, 
MD, provost and executive vice 
president for academic affairs at 
Thomas Jefferson University, and the 
Anthony F. and Gertrude M. DePalma 
Dean of Sidney Kimmel Medical 
College. “The Caroline Kimmel 
Biomedical Research Building will 
serve as a magnet for scientific talent 
and will bolster our status as an R2 
National Research University.”
The new facility will greatly expand 
Jefferson’s research capacity and, 
along with the Bluemle Life Sciences 
Building, will create a “research 
corridor” along Locust Street. 
“I could not be more pleased about 
this gift; in fact, I am ecstatic,” says 
Sidney Kimmel. “In one act, I have 
been able to honor my wonderful 
marriage to Caroline, my hometown 
of Philadelphia; Thomas Jefferson 
University, which I call the soul of the 
city; and cancer research, to which 
I have devoted so much of my time 
and resources. What more could I 
ask for? I am so fortunate, frankly 
blessed, to have this opportunity.”
Research is a cornerstone of the 
university and Jefferson’s $1 billion 
Reimagine campaign, focused 
on four key themes: to support 
talented faculty and students; to 
create spaces that heal and inspire; 
to unite communities for health 
equity; and to fuel discoveries that 
will improve lives. The landmark gift 
will round out Jefferson’s distinctive, 
integrative approach, which includes 
programmatic basic science as well 
as clinical and applied research.
“Caroline and Sidney Kimmel have 
always been able not only to see the 
future but to make it more optimistic 
for everyone,” says Stephen K. Klasko, 
MD, MBA, president of Thomas 
Jefferson University and CEO of 
Jefferson Health. “It is especially 
gratifying that this will be called 
the Caroline Kimmel Biomedical 
Research Building, as Mrs. Kimmel 
has been an invaluable leader on 
the advisory council of the Sidney 
Kimmel Cancer Center at Jefferson.”
The Kimmels have been extremely 
generous benefactors to Jefferson, 
giving more than $200 million 
over the years. In 2014, they made 
the largest gift in Jefferson’s 
history—$110 million to the medical 
college, which was then renamed 
Sidney Kimmel Medical College. In 
addition, their donations established the 
Sidney Kimmel Cancer Center and lent 
transformational support for research 
into the prevention of cardiovascular 
disease.
“Sidney has proven once again that 
he’s an incredible humanitarian and 
philanthropist,” says Caroline Kimmel. 
“But where he really shines is as a 
husband! I’m profoundly grateful to 
have my name and our 20th anniversary 
celebrated in such a meaningful way at 
Jefferson. This moment forever links 
our personal commitment to cancer 
research, our legacy, and our abiding 
love. I couldn’t be happier!” 
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Jeffersonians Lend a Hand 
to New Nobel Laureates 
Researching How Genes and 
Oxygen Interact
In October the Nobel Committee for 
Physiology or Medicine highlighted 
past discoveries by Jeffersonian 
doctor scientists as crucial 
forerunners to the work of this year’s 
Nobel laureates. Gregg Semenza, 
MD, Sir Peter Ratcliffe, MD, and 
William Kaelin, MD, won the Nobel 
Prize in Medicine for their separate 
investigations on how genes react to 
oxygen levels. 
According to the committee, the 
work of Drs. Semenza, Ratcliffe, 
and Kaelin continued key findings 
in the field from Allan J. Erslev, MD, 
director of hematology and the 
Cardeza Foundation for Hematologic 
Research from 1963 to 1985, and his 
mentee, Jaime Caro, MD, a former 
fellow at the Cardeza Foundation 
and currently a lecturer at Jefferson’s 
College of Population Health.
While the Nobel-winning trio dealt 
with the cutting-edge specifics 
of oxygen flux and cell survival, 
Dr. Erslev first made headway into 
the same mystery 60 years ago. 
Around the time Dr. Erslev arrived at 
Jefferson in 1959, he discovered that 
kidney cells react to the low oxygen 
of anemia by releasing a hormone 
that increases the production of a 
certain type of red blood cell. This 
hormone, called erythropoietin, 
keeps people alive at high altitudes 
where they may struggle to breathe.
After Erslev discovered how 
cells manage oxygen-limited 
environments, a long arc of 
discoveries remained before science 
would arrive at the DNA-scale focus 
of Ratcliffe, Kaelin, and Semenza. Dr. 
Caro emerged to bridge the gap.
Working with both Erslev and 
Ratcliffe, Kaelin, and Semenza, Caro 
pioneered decades of research that 
illuminated gene “expression,” the 
pattern of how genes are shut off 
and turned on, in regard to cellular 
oxygen levels. 
The Nobel committee that awarded 
this year’s prize cited Caro no 
fewer than five times in tracing the 
research that made the Nobel Prize–
winning work possible.
“If they were able to give the prize to 
four people, instead of the maximum 
of three, Dr. Caro would have been 
named,” says Steven E. McKenzie, 
MD, PhD, the Thomas D.M. Cardeza 
Professor of Medicine and the 
Tocantins-Haurani Director of the 
Cardeza Foundation for Hematologic 
Research and the Division of 
Hematology. 
The Erslev Lecture at Medicine Grand 
Rounds has featured Ratcliffe and 
Semenza in the past, and in spring 
2020 the series will feature Kaelin, 
giving Caro the chance to catch up 
with his newly lauded colleague.
 
In Joining National Academy, 
Ophthalmologist Julia Haller 
Sees an Opportunity
This October the National Academy 
of Medicine named Julia Haller, 
MD, professor and chair of the 
Department of Ophthalmology at 
Sidney Kimmel Medical College and 
ophthalmologist-in-chief at Wills 
Eye Hospital, among its most recent 
inductees.
On Campus
| Julia Haller, MD
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Educated at Princeton and Harvard, 
Haller served as the first female 
chief resident at Wilmer Eye Institute 
at Johns Hopkins. She’s published 
350 articles and book chapters, 
established international renown 
as a retina surgeon, and as chief 
ophthalmologist at Wills Eye, she is 
the first woman to lead a top- tier eye 
hospital in the U.S.
In joining the academy, Haller is 
the fourth Jeffersonian and the 
first female Jeffersonian to receive 
the honor. While she’s excited to 
boost Jefferson’s signal, Haller is 
also eager to raise ophthalmology’s 
profile. Haller will be one of just 
15 ophthalmologists out of the 
academy’s 2,200 members. Eye 
doctors make up less than 1% of the 
academy rolls. 
“When we talk about quality of 
life, vision is often left out of the 
conversation,” Haller says. 
As to why eye health is so often 
overlooked, Haller says that 
ophthalmology is a victim of its own 
success. 
“Ophthalmology has been at the 
tip of the spear,” she says, noting 
that the discipline was the first to 
utilize gene therapy and among 
the first to use lasers and minimally 
invasive techniques. Thanks to 
these advancements, eye-surgery 
patients are soon outpatients. 
Ophthalmology as a whole, Haller 
says, “doesn’t take up a lot of space 
in the hospital.”
In broadening ophthalmology’s 
bandwidth at the academy, Haller 
sees a chance to talk not only about 
innovation, but about access.
“There are two ends of the 
challenge,” she says. “Developing 
new ways to treat blinding diseases, 
and then on the other side, getting 
the basic stuff out there to the 
people who need it and don’t have 
access.”
According to Haller, becoming part 
of the academy, among the most 
brilliant minds of American medicine, 
will help to identify the solutions to 
these and many other challenges. 
“That’s the sort of crucible where 
you get new ideas,” she says.
 
Jefferson Celebrates Five 
Decades of Restoring Hope 
with Rehabilitation Medicine
On October 24, the Jefferson 
Department of Rehabilitation 
Medicine celebrated its 50th 
anniversary and honored the 
esteemed educator, mentor, and 
physician John F. Ditunno, Jr., 
MD, for his leadership as founding 
chairman of the department from 
1969 to 1997. 
As the first chair of the Department 
of Rehabilitation Medicine, Dr. 
Ditunno incorporated the disciplines 
of neurology, surgery, speech, 
social work, and psychiatry into the 
department’s approach to educating 
physicians to restore patients to 
health and hope. 
“We always envisioned creating a 
center of excellence,” Ditunno says.
At the same time, Ditunno led the 
department to develop innovative 
treatments for spinal cord injuries. 
“Our measures became the standard, 
nationally and internationally,” 
Ditunno says.
The Department of Rehabilitation, 
with help from the Office of Alumni 
Relations, held the anniversary 
event at the elegant Cescaphe 
Ballroom in Philadelphia’s Northern 
Liberties neighborhood and treated 
approximately 150 alumni, staff, 
family, and friends to hors d’oeuvres, 
signature cocktails, dinner, dessert, 
and music. 
John Melvin, MD, who succeeded 
Ditunno as chair of the department, 
gave a heartfelt tribute to his 
predecessor and presented him 
with an award in recognition of 
his decades of dedication to the 
department, its students, and his 
colleagues
“Dr. Ditunno is a true icon,” says 
Steven R. Williams, MD, the third 
and current chair of the department 
and the dean for the College of 
Rehabilitation Sciences. 
As with so much of American 
medical history, the legacy of 
rehabilitation medicine runs deep at 
Jefferson. 
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In the 20th century, Jefferson 
alumnus Frank H. Krusen, MD ’21, 
transformed the field once known 
as “therapeutics” by focusing on the 
restoration of patients’ mobility and 
strength. As the “father of physical 
medicine,” he sought to rehabilitate 
his patients for the tasks of daily, 
independent living. 
Another Jefferson alumnus, John 
W. Goldschmidt, MD ’54, built on 
Krusen’s innovations by pioneering 
an interdisciplinary approach that 
formed the basis of what became 
the Department of Rehabilitation 
Medicine at Thomas Jefferson 
University. 
After launching in 1969 under 
Ditunno’s guidance, the department 
grew to include a training program 
that has placed decades of 
Jefferson physicians throughout the 
area’s hospitals, including Magee 
Rehabilitation Hospital, a flagship 
of the discipline and a Jefferson 
partner. 
In celebrating the 50th anniversary, 
the Department of Rehabilitation 
Medicine raised $84,000 toward 
the John F. Ditunno, Jr., MD, 
Endowed Research Fund. During 
the event an anonymous alum 
promised to match all funds up to 
$50,000. Once the fund reaches a 
$100,000 endowment requirement, 
Dr. Williams and the rehabilitation 
medicine faculty will direct $5,000 
of the fund every year toward 
a research project within the 
department. 
“I feel very honored,” says Ditunno 
on having a fund in his name. “The 




to Improve Patient Safety 
Training Taps Jefferson
In September the Accreditation 
Council for Graduate Medical 
Education (ACGME) invited a 
Jefferson team led by Rebecca 
Jaffe, MD, associate professor 
of hospital medicine at SKMC, 
to join an 18-month nationwide 
collaboration aimed at developing 
transformational changes to improve 
patient safety outcomes.
In organizing the Collaborative 
on Pursuing Excellence in Clinical 
Learning, ACGME chose just 10 
clinical learning institutions to join 
the cohort, and selected Jefferson 
as a “New Pathway Leader” along 
with institutions such as the David 
Geffen School of Medicine at UCLA, 
University of Maryland, University 
of South Florida Morsani College 
of Medicine, and University of 
Tennessee Health Sciences Center.
Over the next year and a half, 
Dr. Jaffe and a four-member, 
multidepartmental team of 
Jeffersonians will meet with other 
participants for three three-day 
sessions to brainstorm and hash 
out ideas and practices on how to 
best train medical students to keep 
patients safe. 
ACGME first established the 
collaborative project in 2017 after 
it conducted site visits to every 
accredited teaching hospital in 
the U.S. To address the needs it 
discovered, ACGME tasks groups to 
find solutions in focus areas such as 
professionalism, resident burnout, 
and safety.
Jaffe’s a natural fit for the job. 
Among her roles at Jefferson, she is 
a safety “bridging leader,” meaning 
that she heads safety initiatives at the 
hospital while training the university’s 
current and future physicians in 
safety practices. 
With a foot in each world, Jaffe 
is always searching for a way to 
integrate the two. Training that fuses 
theory and lived experience, she 
reasons, will produced safer, more 
seasoned physicians.
“Telling people what to do is not 
that effective. We need to show 
them why their engagement in 
safety processes is so meaningful to 
patients and providers,” says Jaffe. 
“That’s the direction that can achieve 
an attitudinal shift.” 
 At present, a lot of education 
around patient safety focuses on 
reporting, Jaffe says. While accurate, 
helpful reporting of medical errors 
is indispensable, Jaffe wants to 
renew focus on mitigation strategies 
and deeper analysis of errors and 
| Rebecca Jaffe, MD
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near-misses. Any advance or insight, 
Jaffe hastens to point out, is most 
effective when woven into the 
residents’ clinical experience. 
Looking forward, however, growth 
in residents’ responsibility and 
autonomy may meet resistance. As 
pay structures for medical services 
shift, so does liability. Hospitals of 
the future may be reticent to entrust 
residents with risky, high-impact 
tasks. 
“If that happens, you’re looking at 
graduates of residency programs 
who are less ready to be doctors,” 
Jaffe says. 
  
Jeffersonians Rise to the Top 
of Philadelphia “Best Of” Lists
Jefferson doctors, nurses, and 
educators have received high 
honors from two Philadelphia-area 
news institutions, the Philadelphia 
Inquirer and Philadelphia magazine. 
On August 15, 2019, the Inquirer 
named seven Jeffersonians at 
its “Influencers of Healthcare” 
ceremony, a celebration of 
healthcare professionals who have 
gone above and beyond to improve 
the lives of their patients and the 
health of the city. 
At the ceremony, held in the 
Crystal Tea Room in the historic 
Wanamaker Building, the Inquirer 
hailed the city’s “heroes of 
healthcare” naming Bon Ku, MD, 
MPP, a specialist in emergency 
medicine, associate professor at 
SKMC, and star of TNT’s Chasing the 
Cure, for an Excellence in Innovation 
Award. The Excellence in Medical 
Research Award went to Richard J. 
Smeyne, PhD, director of Jefferson’s 
Comprehensive Parkinson’s Disease 
and Movement Disorder Center at 
the Vickie and Jack Farber Institute 
for Neuroscience, for his research 
into the cell biology of Parkinson’s 
disease. 
For Physician of the Year, the 
Inquirer named Julia A. Haller, 
MD, professor and chair of the 
Department of Ophthalmology and 
ophthalmologist-in-chief at Wills Eye 
Hospital. Finally, Austin L. Chiang, 
MD, MPH, assistant professor, 
director of the Endoscopic Bariatric 
Program, and chief medical social 
media officer, walked away with the 
night’s Rookie of the Year Award.
Other honorees include Marc 
J. Altshuler, MD, director of the 
Jefferson Center for Refugee Health, 
for the Excellence in Patient Care 
award; Eddie Welsh, RN, a nurse 
at Jefferson Frankford Hospital, 
as Nurse of the Year; and Resa E. 
Lewiss, MD, vice chair and professor 
of ultrasound point-of-care, for the 
Outstanding Educator award. 
The celebration also featured 
Jeffersonians Anuj Shah, MD, 
a physician resident training in 
emergency medicine at Thomas 
Jefferson University Hospital, and 
Brian Sweeney, RN, MBA, FACHE, 
chief operating officer at Thomas 
Jefferson University Hospitals, 
as panelists on a discussion of 
the effect of millennial consumer 
behavior and the future of 
healthcare.
Jefferson physicians also made 
a strong showing in the pages of 
Philadelphia magazine, where over 
500 Jeffersonians appeared in the 
magazine’s 2019 “Top Doctors” 
issue. These Jefferson physicians 
were nominated by their peers as 
providing the very best care available 
in Southeast Pennsylvania, South 
Jersey, and Delaware. 
 
Jefferson’s “Health Nexus” 
Podcast Launches, Tackles 
Hahnemann Shutdown
In September, Jefferson launched 
the Health Nexus Podcast, a brand 
new audio platform to highlight 
the inspiring stories that pass 
through the hospital and university 
doors. Each episode offers a rare 
opportunity to follow physicians, 
patients, students, researchers, 
and leaders as they navigate the 
transforming healthcare landscape. 
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The Health Nexus Podcast took off 
with a three-part series delving into 
the Hahnemann University Hospital 
closure and its impact on Jefferson.
Episode one traces the impact 
Hahnemann’s shutdown has had 
on the Jefferson Emergency 
Department. Hospital president 
Richard Webster, RN, MSN, and 
department staff members lead 
listeners through their efforts to 
deal with the spiked level of activity 
Jefferson’s ER now faces. Jefferson 
braced for the uptick beforehand 
with high-level analysis and met the 
challenge head on. The hospital 
revamped intake and triage protocol, 
assigned “vertical attending” doctors 
to flexibly respond to needs, and 
worked with the city to streamline 
the increased flow of ambulances.
In episode two, we meet Adam J. 
Sagot, MD, who within the space of 
a few hours witnessed the birth of 
his daughter, Lennon, and learned 
that his upcoming fellowship in 
child and adolescent psychiatry 
through Drexel University College of 
Medicine and Hahnemann University 
Hospital might disappear. Jefferson 
sprang into action, opened its doors, 
and found space for Dr. Sagot and 
more than 70 other postgraduate 
trainees, salvaging an opportunity 
from the Hahnemann crisis.
“We care deeply for our residents 
and fellows,” Mark L. Tykocinski, 
MD, provost and executive vice 
president for Academic Affairs for 
Thomas Jefferson University, and 
the Anthony F. and Gertrude M. 
DePalma Dean of Sidney Kimmel 
Medical College, tells the Health 
Nexus Podcast. “Residency training 
is what brings the pieces of your 
[medical school] education together. 
It not only gives you the clinical 
perspectives, but continues your 
development as a person and a 
professional.” 
What’s more, securing a home for 
postgraduate trainees displaced by 
the Hahnemann closure ensures 
that those talents will continue to 
contribute to a healthier Philadelphia, 
Tykocinski says.
Finally, in its third installment, the 
Health Nexus Podcast takes us into 
labor and delivery care, a crucial 
Jefferson service that faces an 
approximate 50% surge in volume 
due to the Hahnemann closure. This 
summer, with Hahnemann suddenly 
unable to meet the needs of over 
1,000 expectant mothers, Jefferson 
expedited the onboarding of 12 
obstetricians and eight midwives in 
just over one week. 
Each episode of the podcast, 
available at thehealthnexus.org, 
delves into the challenges and 
complexities of contemporary 
healthcare and brings you the voices 
at the heart of these transformations.
In other words: “Our stories,” says 
host Gianna DeMedio, “told our way.”
 
Jefferson Appoints John 
Lauriello, MD, to Chair 
Department of Psychiatry and 
Human Behavior 
In September John Lauriello, MD, 
became the chair of the Department 
of Psychiatry and Human Behavior 
at SKMC and senior vice president 
of psychiatry for Jefferson Health. 
Formerly the chair of psychiatry 
at the University of Missouri, Dr. 
Lauriello held the Robert J. Douglas, 
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MD, and Betty Douglas Distinguished 
Professorship in Psychiatry and 
oversaw a major expansion of the 
department and the opening of the 
acclaimed University of Missouri 
Psychiatric Center.
Dr. Lauriello has written and 
contributed to more than 100 
publications and is an expert 
investigator in the diagnosis 
and treatment of schizophrenia. 
Lauriello’s dedication has earned 
him a place among “Best Doctors 
in America” from 1998 to 2018 
and the 2011 Henry P. and M. Page 
Laughlin Alumnus of the Year Award, 
the highest alumni honor offered 
from Temple University’s Lewis Katz 
School of Medicine. Lauriello won 
election to the American College of 
Psychiatrists in 2014, and in 2018 was 
named a distinguished fellow of the 
American Psychiatric Association.
Before his work at the University 
of Missouri, Lauriello led the 
schizophrenia research group at 
the University of Mexico and later 
became the executive medical 
director of the UNM Psychiatric 
Center. He also served as a UNM site 
principal investigator for the Mental 
Illness and Neuroscience Discovery 
(MIND) Institute, a consortium 
of universities and institutions in 
Minnesota, Massachusetts, and New 
Mexico.
A graduate of Yale University, 
Lauriello completed medical school 
at Temple University and residency 
at New York Presbyterian Hospital’s 
Payne Whitney Psychiatric Clinic. 
He went on to fellowships focused 
on psychopharmacology and 
psychobiology at the University of 
California, San Diego and Stanford 
University.
At Jefferson, Lauriello not 
only hopes to strengthen his 
department’s academic standing, 
but also plans to partner with 
clinical pillar leadership to create 
an enterprisewide behavioral health 
strategy. 
In coming to Philadelphia, Lauriello 
arrived with his wife, Naomi 
Lauriello, MD, a neonatologist who 
will be working in the Department 
of Pediatrics at Nemours/Alfred I. 
duPont Hospital for Children.
Wills Eye Hospital Presents 
Inaugural Awards at Wills Eye 
Ball
Wills Eye Hospital presented 
four inaugural awards to honor 
outstanding leaders and esteemed 
benefactors at the Wills Eye Ball on 
Saturday, November 2, 2019, at the 
Four Seasons Hotel in Philadelphia. 
The gala celebrated the 60th 
anniversary of the Wills Eye Retina 
Service and paid tribute to its 
innovative breakthroughs, best-in-
class fellowship training program, 
patient-centered service, and life-
changing impact. 
Stephen K. Klasko, MD, MBA, 
president of Thomas Jefferson 
University and CEO of Jefferson 
Health, and Steven H. Korman, a 
Wills Eye benefactor, civic leader, 
and founder of Korman 
Communities, were recognized with 
the Strategic Partnership Awards. 
Dr. Klasko was selected for his 
visionary leadership in reimagining 
the intersection of healthcare and 
higher education and his ongoing 
support of Thomas Jefferson 
University’s partnership with 
Wills Eye Hospital. Wills Eye is an 
independent ophthalmology hospital 
and serves as the Department of 
Ophthalmology for Sidney Kimmel 
Medical College at Thomas Jefferson 
University. Korman was recognized 
for his support of strong and healthy 
communities through leadership 
roles in housing, nutrition, and 
healthcare initiatives in Philadelphia.  
Other award recipients include 
Philadelphia Mayor Jim Kenney, who 
received the James Wills Leadership 
Award in recognition of his support 
of Wills Eye Hospital and the board 
of directors of City Trusts, which 
provides oversight to Wills Eye, 
and Jay S. Duker, MD, director of 
the New England Eye Center and 
professor and chairman for the 
Department of Ophthalmology 
at Tufts Medical Center and Tufts 
University School of Medicine, who 
received the Vickie and Jack Farber 
Vision Research Award in recognition 
of his significant contributions to 
vision research. 
“The pioneering Retina Service is a 
core part of Wills Eye Hospital, and 
together we are so very proud of our 
rich history of training, clinical care, 
and research,” says Carl D. Regillo, 
MD, FACS, chief of Retina Service 
at Wills Eye Hospital. “We look 
forward to celebrating this milestone 
60th year and ushering in this next 
exciting era in new treatments and 
cures for patients confronting eye 
disease in its many forms.”
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On Campus
Bright lights, big news, sparkling music, high 
energy, terrific honorees—the 17th Annual 
Jefferson Gala was a smashing success. The 
sold-out hall and record-breaking funds 
raised, $1.8 million, were made even better 
when an anonymous donor made an on-the-
spot gift of $200,001, just so Jefferson could 
top the $2 million mark. Proceeds benefited 
stroke education, outreach, and prevention 
efforts in underserved Philadelphia 
neighborhoods, as well as special initiatives 
of the Farber Institute for Neuroscience. 
High points included “breaking news” of 
a $70 million gift from the Sidney Kimmel 
Foundation to fund a new Caroline 
Kimmel Biomedical Research Building, an 
announcement that the Reimagine campaign 
had raised $703 million of its $1 billion goal, 
and the honoring of Robert Rosenwasser, 
MD, MBA, with the Achievement Award in 
Medicine and Andréa and Kenneth Frazier 
with the Award of Merit. Rosenwasser is 
a neurosurgeon and president and CEO 
of the Vickie and Jack Farber Institute for 
Neuroscience. Andréa Frazier is founder 
of the interior design firm Frazier Designs 
and a member of the Vickie and Jack 
Farber Institute for Neuroscience Campaign 
Committee. Kenneth Frazier is chairman and 
CEO of Merck.
The evening was topped off with dancing 
to music by the band Well Strung, which 





Gala honorees Robert Rosenwasser, MD, MBA, Kenneth Frazier, and Andréa 
Frazier, with Stephen K. Klasko, MD, MBA
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Generosity Goes 
Both Ways
Have you ever felt inspired watching 
someone act with compassion? Have 
you been moved seeing a stranger help 
a stranger? I have. It reminds me of all 
that’s best about humanity.
 
Psychologists call the experience 
“elevation.” Someone witnesses an act 
of kindness, and it makes them want 
to help others and become a better 
person.
 
Working with benevolent Jefferson 
alumni, I’m privileged to have an 
“elevated” front-row seat for witnessing 
generosity. 
 
Recently, I had the opportunity to be in 
the room when a Jefferson scholarship 
recipient met her benefactor.
 
For the past three years, Hannah 
Garrigan has been a Liss Scholar 
at Sidney Kimmel Medical College, 
receiving a scholarship established by 
Amy Liss and her late husband, Henry 
Liss, MD ’48.
When they met, the connection was 
undeniable. Sitting side by side on the 
couch this fall, it was clear how grateful 
Hannah, 26, and Amy, 88, were for one 
another.
 
“I would not be where I am today 
without people like you,” Hannah told 
Amy, explaining that the rising cost of 
medical education and the expense of 
living in Philadelphia is overwhelming. 
“The loans don’t always cover what 
things actually cost—and then there’s 
the loans themselves.”
 
Amy understood, and told Hannah that 
was why she and her husband started 
the scholarship.
 
“Henry started Jeff in ’44, and he 
came to realize how fortunate he and 
his classmates were in having the GI 
Bill,” she said. Dr. Liss had served as 
a hospital corpsman in the U.S. Navy 
during the war, and was able to attend 
college and medical school without 
incurring any costs or loans. He went 
on to be a pioneer in neurosurgery.
 
“We realized that today’s medical 
students don’t have that kind of 
financial support,” Amy said. And so, 
the couple established the first Liss 
Scholarship Fund in 1991, designated 
for students with demonstrated 
financial need. A second fund was 
established in 2009 and earmarked for 
students with an inclination toward the 
practice of family medicine. To date, 
almost $900,000 has been awarded to 
70 Liss Scholarship students.
 
Amy has great hopes for her scholars. “I 
hope they’re fulfilled in whatever path 
they choose,” she said, “and  I hope 
that they will have the same feelings of 
respect and appreciation for Jefferson 
that my husband had, and that they will 
do whatever they are able someday to 
support the school.”
 
Generosity goes both ways. A gift fuels 
positive change for others, and the act 
of giving uplifts the giver. Generosity 
makes people better, and it makes 
better people too. I feel enormously 
grateful to be part of the Jefferson 
philanthropic ecosystem.
 
One of our goals through the 
Reimagine campaign is to endow 100 
scholarships, so that bright students 
like Hannah will have the opportunity 
to give back to humanity through the 
noble profession of medicine.
 
If you’re interested in learning more 
about how to create a scholarship, or 
if you’d just like to share a story about 
something inspiring you’ve witnessed, 
please contact me. I’d love to hear from 
you.
 
To learn more about Hannah, read 
“Leaving the Comfort Zone” on page 
46, or watch a video of Amy and Hanna 
meeting each other at 
Jefferson.edu/LissScholarship. 
Elizabeth A. Dale, EdD, MPA
Executive Vice President and
Chief Advancement Officer 
Office of Institutional Advancement
215-503-5138
elizabeth.dale@jefferson.edu
     @elizabeth__dale
Please contact me if you’d like to 
learn more about the doors you can 
open and lives you can change. I’d 
love to hear from you.
A Message from Elizabeth A. Dale
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Discovery
| Illustration by Shae Berler Goudreau
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It Takes 
a Village
How does a lab in Philadelphia study a 
disease endemic to sub-Saharan Africa? 
With a lot of help. By Zach Nichols
I
n some places, you see children gingerly leading the 
elderly—their eyes milky blind—to work the fields, 
dependent on the young to find their way. In other places, 
whole villages are emptied of people, human sounds 
replaced by buzzing flies and the rush of a nearby river.
This is onchocerciasis—river blindness—a so-called “neglected 
tropical disease” that affects 15.5 million people, mostly in sub-
Saharan Africa with incidences in South and Central America. 
The disease is spread by black flies, which breed in fast-moving 
water, but is caused by Onchocerca volvulus, a tiny parasitic 
worm. 
The worm is David Abraham, PhD’s white whale. A professor of 
microbiology and immunology as well as the associate dean of 
undergraduate medical education and academic affairs, he has 
spent much of his career studying O. volvulus, part of a group 
of parasites known as filarial worms, which include well-known 
pests like heartworms. 
Our antagonist begins its byzantine life cycle as a microfilaria, 
its larval stage, living in human skin tissue until a black fly 
comes along in search of a blood meal. The larva is ingested 
by the black fly, moving to the gut, where it matures to its 
second stage before moving back to the fly’s proboscis (mouth 
parts). After a few weeks, it is ready to depart its host the next 
time the fly feeds on a human.
Entering the second human host through the fly’s saliva, the 
larva takes up residency deep in the skin, forming a nodule, 
where it remains for the next six to 12 months until it is a fully 
mature adult worm. If a male and female are present in the 
same host, the male will make its way 
through the skin to the nodule that houses 
the female, where they will mate. After 
gestation, the female will lay between 700–
1,500 microfilariae each day, which will 
spread throughout the skin until another 
black fly comes along. 
Unsurprisingly, blindness tops the 
symptoms list, though it typically comes as 
a kind of parting shot from the adult worms 
that make their way to a patient’s head and 
face. When the microfilariae die, bacteria 
are released from their corpses and the 
body’s inflammatory response to these 
bacterial invaders can cause damage to the 
retinas. Over time, enough damage can 
lead to full blindness.
Severe as that side effect is, some say 
the accompanying dermatitis produced 
by the larvae is even worse. “It’s so bad 
that people will take hot metal to their 
skin to find some relief,” Abraham says. 
The larvae can cause much of a patient’s 
body to become rough or “lichenized” and 
depigmented. In more extreme cases, the 
skin become so inelastic that organ hernias 
form.
Abraham’s work on a river blindness 
vaccine—none currently exists—began 
in 1988 when the Edna McConnell Clark 
Foundation offered to support his research. 
They asked, “Does the immune system 
respond to Onchocerca volvulus larvae?” 
As it turns out, there is an immune response 
to the worm. The body can “see” it and 
mount a defense. 
Current medical treatments involve 
delivering doses of ivermectin, a general-
use antiparasitic, to at-risk populations 
every year for up to 30 years. This 
multidecade horizon—aimed at interrupting 
the spread of microfilariae—is made 
difficult by the rural life of affected 
populations and the need to track them for 
extended timespans. Vaccination, on the 
other hand, is a one-and-done preventive 
intervention that would inoculate children 
against the infection.
Before developing a vaccine, investigators 
had to get O. volvulus to “hold still,” 
as the parasite tends to move about 
once introduced into a host (lab mice 
in this case), making extraction and 
monitoring a challenge. To resolve this 
issue, Abraham and his team utilized tiny 
diffusion chambers that keep the worms 
from straying. Covered with microns-
wide holes that allow immune molecules 
and cells to interact with the worm, the 
minuscule holding chambers allow the 
team to observe “the scene of the crime” 
and understand in a fine-grained way what 
molecules are involved in a protective 
immune response. (Read “Know Thy Self” 
in the Fall 2019 issue of The Bulletin to 
learn more about the uses for Abraham’s 
chambers).
“We were sent antigens from different 
labs around the world,” recalls Abraham. 
“It was our job to see what response they 
elicited, as well as whether the response 
could be increased in combination with 
other known enhancers.” The collaborators 
developed an antiparasite cottage industry, 
vetting targets and brainstorming possible 
solutions together. 
The Clark Foundation eventually moved 
on to support other new ventures, having 
fulfilled its mission of jump-starting 
research programs for this particular 
neglected tropical disease. “They’d 
assembled this whole group of people,” 
Abraham says. “We now have larvae 
producers and health screeners in Africa 
and at universities throughout the world, 
antigen producers, human immunologists, 
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and my parasite group—all arranged 
around this one goal.”
The National Institutes of Health took 
up the challenge next, providing 
support to continue the basic 
science research required for the O.  
volvulus vaccine’s development. A 
Small Business Innovation Research 
(SBIR) grant enabled the O. volvulus 
collaborators to finalize their list of 
antigen targets and to optimize the 
“recipe.” Now partnered with PAI 
Life Sciences, a Seattle-based health 
sciences firm with expertise in vaccine 
development, the team is on its way to 
market.
But before they could finish, they 
wanted to ensure that their treatment 
would work against the hardiest 
possible specimen. This is essential 
to developing a working vaccine that 
can kill not just sickly, weak worms 
out of place but healthy parasites in 
their native habitat. A species like O.  
volvulus, with its just-so life cycle, 
makes this of the utmost importance, 
as the conditions under which they 
flourish are nothing if not particular.
Funded by the Bill & Melinda Gates 
Foundation, the Abraham lab 
engineered immunodeficient mice 
with a human immune system by 
injecting them with human umbilical 
cord stem cells, populating their 
bodies with the usual cast of T and 
B cells. The team went further by 
grafting human skin and muscle cells 
into their humanized mice to better 
replicate where O. volvulus spends 
much of its life, lengthening the 
worms’ life spans to over three months 
and increasing their size fourfold.
They are currently testing the vaccines 
in collaborative cross-mice models 
to determine the most effective 
combination of antigens and adjuvants 
(immune enhancers). “These mice 
are bred to be as genetically diverse 
as possible with the aim of getting 
reproducible results,” Abraham 
explains. “The idea is to replicate as 
closely as possible the kind of diversity 
you’d find in a population of people.”
The aim is to understand which 
molecular target works best and how 
that “best vaccine” functions. This last 
piece, aside from satisfying curiosity, 
will let them know their vaccine is 
working once it’s finally administered 
to the public. This will save valuable 
time, as they can determine through 
a simple blood test whether immunity 
has taken hold rather than waiting a 
year for the worms to complete their 
life cycle.
There is still some distance to go, 
more tests to be done, and regulators 
to satisfy, but Abraham and the 
international team he is a part of are 
closing in on the vaccine that’s been 
decades in the making.
 
Onchocerca volvulus has left 
countless individuals sightless and 
homeless, and entire villages empty 
and silent. But on the horizon the 
researchers can see a vision of what 
is to come: A world where the young 
look at their elders and have their gaze 
met in return, and villages where rivers 
do not mean foreboding, where the air 
is once again filled with voices. 
| Provided by David Abraham, PhD
| Illustration by Megan Plescha
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R
obert Rosenwasser, MD, MBA, is part 
neurosurgeon, part historian. He revels in telling 
the tale of how Jefferson vaulted into medical 
history in the late 19th century by performing 
the first-ever brain tumor surgery in the country. 
With just a mere mention of  “The Gross Clinic,” he 
launches into a TED-like talk full of trivia nuggets about 
the painting—including how artist Thomas Eakins inserted 
himself into the piece. And he can spout every detail of 
a little-known, but medically pioneering, Civil War–era 
hospital in Philadelphia.
Rosenwasser, the Jewell L. Osterholm, MD, Professor 
and Chair of the Department of Neurological Surgery, is 
the president of the Vickie and Jack Farber Institute for 
Neuroscience at Jefferson Health. He is also the architect 
of the institute, stacking the building blocks to create 
the world-class program recently named “best in the 
region”—and number 21 in the country—for neurology and 
neurosurgery in U.S. News & World Report’s 2019–2020 
“Best Hospitals” listing.
Sporting a gleaming gold brain lapel pin that boasts 
membership in the W.W. Keen Society—named for the 
pride of Jefferson, pioneering surgeon William Williams 
Keen—Rosenwasser is quick to enthusiastically tick off fun 
and fascinating facts from more than a century and a half 
of Jefferson’s history, leading up to today’s litany of “firsts”: 
first in the region to perform stereotactic radiosurgery 
for brain tumors and vascular malformation; first to offer 
the Gamma Knife; first in Philadelphia to perform asleep 
deep brain stimulation surgery for Parkinson’s disease; first 
dedicated stroke center in Philadelphia; first in the region 
to establish a university-based mobile robotic healthcare 
teleconsulting system; and first academic medical center-
based mobile stroke unit in the region, just to name a few. 
It is that enthusiasm that has transformed the 
neurosciences from individual departments to the all-
encompassing, nationally renowned Vickie and Jack 
Farber Institute for Neuroscience. Dubbed “the House 
that Rosenwasser Built,” it is an institution where all 
departments in the neurosciences have a seat at the table, 
and a place that encourages a cohesive, collaborative 
atmosphere to foster great ideas.
“When I got here [in 2008], the hospital and university 
leadership made the commitment to invest in structured, 
formal clinical service lines—one of them was the 
neurosciences,” says Mark L. Tykocinski, MD, provost and 
executive vice president for academic affairs at Thomas 
Jefferson University, and the Anthony F. and Gertrude M. 
DePalma Dean of Sidney Kimmel Medical College. 
“The logical place to start was with neurosurgery because 
we had this incredible and unique chair in Robert 
Rosenwasser,” Tykocinski says. “Robert got it right from the 
beginning. He hit the ground running, and as he ran, we 
ran with him. Robert catapulted us forward, and continues 
to do so today.” 
Solving the Puzzle
Jefferson Neuroscience Leads the Way in “the House that Rosenwasser Built”
BY  C I N DY  L E FL E R
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A Distinguished History
Jefferson’s rise to the top of the field of neurosurgery 
began in the 19th century when Jefferson Medical 
College (now Sidney Kimmel Medical College) professor 
of surgery Samuel Gross, MD 1828, penned his 
pioneering textbook, System of Surgery, which focused 
on disorders of the nervous system. His work paved the 
way for William Williams Keen, an 1862 alumnus who 
earned the sobriquet “America’s first brain surgeon” 
when, in 1887, he became the first surgeon in the 
country to successfully remove a primary brain tumor. 
Adding to his celebrity, Keen also secretly operated on 
President Grover Cleveland on the presidential yacht, 
The Oneida, to remove verrucous carcinoma from the 
roof of his mouth, and later served as a consultant to 
President Franklin Delano Roosevelt after he contracted 
poliomyelitis. 
During the Civil War, Keen joined fellow surgeons 
George Read Morehouse and S. Weir Mitchell at the 
Turner’s Lane Hospital in Philadelphia (located on 
a then-country estate between Girard College and 
Eastern State Penitentiary), where they cared for soldiers 
with peripheral nerve injuries. Keen and his colleagues 
authored several papers, including Gunshot Wounds and 
Other Injuries of the Nerves, which introduced medical 
concepts such as causalgic pain, reflex dystrophy, and 
paralysis. The authors’ groundbreaking work effectively 
led to the founding of American neurology.
Keen served as the chairman of the division of surgery 
at Jefferson from 1889 until 1907. Despite its reputation 
for excellence in neurosurgery, an official division within 
the Department of Surgery wasn’t established until 1943, 
and didn’t become a separate department until 1969. The 
next five years saw tremendous growth, with a move to 
larger facilities that incorporated research laboratories, 
an overhaul of the residency program that included 
collaboration with the neurology department, and the 
addition of its own residency program.
In 1974, Jewell L. Osterholm, MD, became the first 
chairman of neurosurgery at Jefferson, and the 
growth continued. Osterholm instituted changes that 
improved medical education, residency, and research 
programs, and increased the number and types of 
surgery performed. He also oversaw the addition of a 
neurosurgical intensive care unit and dedicated operating 
room, and the establishment of the Regional Spinal Cord 
Injury Center of Delaware Valley. 
Osterholm left the chairmanship in 1994, but remained 
active in academic and research areas for years 
afterward. In 2010, Jefferson established the first 
endowed chair in neurosurgery in his name. Osterholm 
passed away in 2017. 
Throughout the next decade, the department continued 
to grow clinically and academically. A spine fellowship 
was created to allow orthopaedic and neurological 
surgeons to train collaboratively, and the endovascular 
and cerebrovascular divisions expanded.
“We had first-mover advantage not only in technology, 
but in skill set,” Rosenwasser says. “There were 
specialized types of neurovascular procedures only 
offered here at Jefferson.” 
...all the moving 
parts and cross-
department teamwork 
have culminated in 
great achievements in 
education, research, and 
patient care.
| Jewell L. Osterholm, MD
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While neurosurgery was flourishing, the rest of the 
neurosciences were making great strides in research, 
clinical care, and education. There was no organized 
neuroscience department at the time, but work was 
being done in the areas of biochemistry, pathology, and 
others affiliated with the specialty. The department of 
psychiatry was small, but active in both patient care and 
physician and researcher training. Each department had 
its own strengths, but operated separately with no cross-
interaction.
Neuroscience got a boost in 2001 when longtime 
Jefferson benefactors Vickie and Jack Farber made a 
$10 million gift to establish the Vickie and Jack Farber 
Institute for Neuroscience. The institute opened its doors 
in early 2002, supporting basic, translational, and clinical 
research for treatments of neurodegenerative disorders, 
including Parkinson’s disease, amyotrophic lateral 
sclerosis (ALS), Alzheimer’s, multiple sclerosis (MS), and 
more.
In 2004, Rosenwasser, who was serving as professor 
of neurosurgery and division chief for Jefferson’s 
cerebrovascular division, was awarded chairmanship 
of the Department of Neurological Surgery. One of the 
first dual-trained vascular neurosurgeons in the country, 
Rosenwasser took the helm of the section just as its staff 
and faculty numbers started to dwindle. 
Unfortunately, Rosenwasser explains, what made 
Jefferson a top-in-the-country organization also made it 
a target for other universities and healthcare systems.
“Jefferson did a very good job of training people, 
and that made them very attractive to prestigious 
institutions throughout the country,” Rosenwasser says. 
“They became valuable assets, and other institutions 
began recruiting them away for division chief and chair 
positions.” 
Several faculty members left for leadership positions at 
other distinguished universities, including Stanford, Duke, 
Tulane, and University of Pennsylvania.
Tykocinski recounts the story of a chair of neurosurgery 
at another institution taunting him about raiding 
Jefferson’s best and brightest: “He said, ‘Lots of luck, 
because we decimated your neurosurgery department,’” 
he recalls. “But I’m a pretty competitive guy, and took 
that as throwing down the gauntlet. I decided to take up 
the challenge.”
That challenge was not only to bolster the neurosurgery 
division, but to take it one step further and create an 
all-encompassing neuroscience service line at Jefferson 
that would elevate every division and subspecialty. 
Luckily, he says, Jefferson’s reputation for excellence 
made it possible to attract other talented people to 
replace those who had left.
In 2014, Tykocinski and Stephen K. Klasko, MD, MBA, 
president of Thomas Jefferson University and CEO of 
Jefferson Health, decided that a “CRISP” approach was 
necessary. CRISP—Clinical and Research Integrated 
Strategic Program—is an innovative method of 
organizing healthcare based on disease focus rather than 
by departments or specialties. 
“We set out to create a true institute in the model 
of having basic science, hardwiring in the clinical 
side as well, and also bringing together the four lead 
departments—neurosurgery, neurology, neuroscience, 
and psychiatry,” Tykocinski says. It was time to start 
putting into place the building blocks of what would 
become a nationally renowned program.
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Building Block—Neurosurgery
The keystone was neurosurgery. Tykocinski says 
Rosenwasser was already known for his skill as a 
surgeon, but a unique talent for entrepreneurialism—he 
has an MBA from Villanova University—and dedication 
to his field made his department a good place to start.
The initial goal, Tykocinksi notes, was to see the 
department doubled in size; instead, it more than 
tripled. 
Aside from recruiting topflight surgeons, physicians, 
and researchers, Rosenwasser put his business 
acumen to work. He began reaching out to smaller 
hospitals in the region that didn’t have neurosurgery 
practices, offering to cover their needs either on-
site or through telepresence support. Through this, 
he created Jefferson Expert Teleconsulting (JET), 
the region’s first university-based mobile robotic 
teleconsulting system. It allows community hospital 
physicians to remotely consult with a Jefferson Health 
neurologist or neurosurgeon to medically evaluate 
neurovascular events, such as stroke or aneurysm, in 
real time to determine whether to continue treatment 
at the community hospital or to transfer the patient 
to a facility that could provide more advanced care. 
The JET network has grown to include 37 hospitals in 
Pennsylvania, New Jersey, and Delaware.
This technology made the region’s first academic 
medical center–based mobile stroke unit (MSU) 
possible. The specially outfitted ambulance is fully 
equipped with a CAT scan machine to bring diagnosis 
and care right to the patient’s door, expediting 
treatment for a time-sensitive disease. The goal is to 
eventually add more mobile stroke units to serve the 
Philadelphia region and South Jersey. 
With Rosenwasser’s expertise in both clinical care and 
entrepreneurialism, neurosurgery was thriving, says 
Tykocinski. “But neurosurgery doesn’t exist in a vacuum. 
It’s highly dependent on having strong neurology and 
neuroscience programs.”
Building Block—Neurology 
Jefferson’s department of neurology has a long and 
storied history in the United States. Established in 1824, 
it was the first division of neurology in the country, 
and S. Weir Mitchell, MD, 1852, a Jefferson graduate, 
is considered “the father of American neurology,” says 
Abdolmohamad M. Rostami, MD, PhD, professor and 
chair of the Department of Neurology and director of 
neuroimmunology and the multiple sclerosis laboratory.
| Abdolmohamad Rostami, MD, PhD
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In 2003, Rostami took the leap from the University 
of Pennsylvania to Jefferson because he “saw an 
opportunity to build a department.” And build it he did.
When he arrived, there were only eight faculty 
members, nine residents, and seven clinical and 
research fellows. With the backing of hospital and 
university leadership, he began recruiting. The 
department is now more than 70 faculty strong, 
and consists of some of the best-funded research 
laboratories in the institute. More than 70 clinical trials 
are ongoing to find the answers to Alzheimer’s disease, 
epilepsy, stroke, Parkinson’s disease, headache, and 
neuromuscular diseases. 
In addition, the department enjoys a robust and well-
respected training program for the next generation of 
physicians and researchers. The department has 27 
residents and 25 postdoctoral clinical and research 
fellows. Each year, it receives more than 750 applications 
for residency slots from students at the country’s top 
medical schools. 
“Residents and fellows who graduate from Jefferson’s 
program are highly sought after by institutions such as 
the National Institutes of Health, Harvard, Columbia, 
Johns Hopkins, and of course, some stay at Jefferson,” 
Rostami says.
He also began a mandatory neuroscience/neurology 
rotation for medical students at Sidney Kimmel Medical 
College because “they are such important aspects of 
medicine that even those who do not want to go into 
neurology should have good knowledge of the nervous 
system,” Rostami says. There are also specialized 
academic programs for nurses and physician assistants.
“My goal was to create a state-of-the-art 
department that would include all the subspecialties 
of neurology, and also create an educational 
environment for all residents, fellows, and junior faculty,” 
he says. He credits his success to his talented faculty and 
staff—and to the hospital and university leadership for 
“understanding the value of neuroscience.” 
Rostami says the bench-to-bedside achievements can 
be directly attributed to the four departments being 
brought together at the Vickie and Jack Farber Institute 
for Neuroscience to work as partners in promoting 
science, furthering education, and improving lives.
“We try to not only help our patients, but also to 
move the boundaries of research—to understand the 
neurological diseases, and find the therapies for these 
diseases,” he says. “And although we have achieved a lot, 
we know we need to do even more. And we will.”
Building Block—Neuroscience
In January 2010, the Department of Neuroscience was 
officially established, bringing together neuroscientists 
who previously had primary appointments in other 
departments, including neurological surgery, neurology, 
pathology, and biochemistry. Internationally renowned 
researcher Irwin Levitan, PhD, was recruited to become 
the new department’s founding chair. 
Levitan, who holds the title of Paul C. Bucker Professor 
and Chair of Neuroscience, had built the neuroscience 
department at the University of Pennsylvania and served 
as its chair for a decade. He was looking for a new 
challenge, and “starting a new department from scratch 
sounded like fun,” he says.
We try to not only 
help our patients, 
but also to move 
the boundaries of 
research...
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“Before about 2001, there was no organized 
neuroscience research community at Jefferson. There 
were neuroscientists, but their faculty appointments 
were in biochemistry or pathology or neurology 
or neurosurgery,” Levitan explains. “The original 
establishment of the Farber Institute (for research) in 
2001 provided some structure for the neuroscience 
research community. By the time the department of 
neuroscience was founded, the Farber Institute had a 
brand for working on neurodegenerative diseases, and so 
my goal was to build on that strength.”
He set about the task of recruiting scientists for his 
department to complement Jefferson’s existing and 
established core group of neuroscience researchers. 
Their goal was to do “basic research” that would have 
implications for fundamental understanding of the brain 
in health and disease. Currently, the department has 14 
faculty members, and between 30 and 50 basic science 
projects running at any given time with a principal 
investigator and postdoctoral or graduate student 
workers. In addition, two academic psychiatrists have 
recently joined the research team; although their primary 
appointments are in the psychiatry department, they 
conduct research in the neuroscience laboratories.
Levitan says the neurosciences at Jefferson are on a “very 
positive trajectory” due to an atmosphere that allows for 
the sharing of ideas and working toward common goals. 
Along with the executive committee, consisting of the 
chairs of neurosurgery, neurology, neuroscience, and 
psychiatry meeting weekly, faculty members are free to 
reach out to other departments at any time.
“Jefferson is an extremely collegial and cooperative place 
to work,” Levitan says. “People here are really eager to 
pitch in and participate and be part of a community.” 
Building Block—Psychiatry
In order to create a complete institute that focused on 
mind-brain disorders, psychiatry had to be part of the 
plan, Tykocinksi says.
Established in 1942, the Department of Psychiatry at 
Jefferson had experienced more than 50 years of growth 
and innovation when Michael Vergare, MD, was recruited 
to become chair of the Department of Psychiatry and 
Human Behavior in 1998. 
 
“We were smaller then, and the focus was more on 
education and clinical care,” he says. However, because 
of insurance company reimbursement rules, there were 
severe limits on the services the department could 
provide.
That changed with the integration into the Vickie and 
Jack Farber Institute for Neuroscience. Being brought 
under the umbrella of the institute in 2016 transformed 
the way Jefferson viewed psychiatry services, allowing 
for wider access to care. It also provided new resources 
for research and recruitment.
Jefferson is an 
extremely collegial 
and cooperative 
place to work. People 
here are really eager 
to pitch in and 
participate and be 
part of a community.
| Daniel E. Kremens MD,JD
Sidney Kimmel Medical College   31
In addition, the department recently added two 
researchers whose work is anchored in psychiatry 
and neuroscience, exploring the genetic and protein 
metabolism associated with psychosis and depression.
Vergare says becoming part of the institute “encouraged 
collaboration among departments and around all 
programs so we could support each other and share 
faculty and ideas,” and he credits Rosenwasser’s vision for 
the advances in the psychiatry department.
“Through Robert’s leadership we coalesced,” Vergare says. 
“His emphasis has always been on advancing excellent 
patient care through strong teams that draw on the best of 
science. His style is to roll up his sleeves and 
work hard in the background to 
strengthen those around him.”
In September 2019, Vergare 
became chair emeritus 
and passed the baton to 
John Lauriello, MD, now 
professor and chair of the 
Jefferson Department of 
Psychiatry and Human 
Behavior, and senior vice 
president of behavioral 
health. 
Lauriello says that 
psychiatry has an important 
place with the other three 
departments. 
“Psychiatry bridges both 
issues of the brain and 
the mind, and offers a 
complementary perspective 
on the underlying pathology 
and clinical care,” Lauriello 
says, adding that he hopes 
to help the already well-respected department grow 
even further. “I want to help rationalize and standardize 
the delivery of clinical psychiatric/behavioral care across 
the entire enterprise [so that we can become] a national 
leader in this endeavor.”
Under One Roof—The House that 
Rosenwasser Built
With the four departments securely under one roof and 
working as a cohesive entity, the blueprint for an all-
encompassing program came together. 
In 2015, the mission of the Vickie and Jack Farber 
Institute for Neuroscience was expanded beyond 
research to include clinical care and training for the 
next generation of physicians and scientists. In 2016, the 
founding benefactors made another transformational $20 
million gift, and Rosenwasser was named president and 
CEO of the institute. 
“Research into devastating neurologic diseases was gaining 
momentum at Jefferson for years. Vickie and I chose to 
make the investment because we want to be part of the 
transformation we know is in process,” says Jack Farber, 
who has served as a member of Jefferson’s board since 
1984, including five years as chairman. 
“Our hope is that no family has to watch a loved one 
disappear into the darkness of Alzheimer’s or ALS or 
Parkinson’s or any brain disease,” adds Vickie Farber, 
whose father succumbed to amyotrophic lateral sclerosis 
(ALS, also known as Lou Gehrig’s disease), and whose 
mother suffered from Alzheimer’s disease.
Also in 2016, the Jefferson Weinberg ALS Center was 
established through a merger between the Farber 
Institute for Neuroscience and the Frances and Joseph 
Weinberg Unit for ALS Research. In July 2018, the center 
was named an ALS Association Certified Treatment 
Center of Excellence.
But there is more to the neurosciences than the Farber 
Institute, Tykocinski says. In addition to the work at the 
institute, there is much being done across a multitude 
of departments at Jefferson, including biochemistry, 
radiology, anatomy and cell biology, neuroradiology, 
neuropathology, and neuro-oncology.
“There are a lot of moving parts to the neurosciences,” 
Tykocinski says. “And all the moving parts and cross-
department teamwork have culminated in great 
achievements in education, research, and patient care.”
For example, combining the strengths of the 
neurosciences and the Sidney Kimmel Cancer 
Center (SKCC) has resulted in a possible vaccine for 
glioblastoma, the most aggressive type of primary brain 
cancer. 
The Farber Institute also partners with Wills Eye 
Hospital in research. The collaboration has resulted in 
a breakthrough eye-saving treatment for children with 
retinoblastoma. 
Further collaboration with Wills Eye was established in 
May 2019, when the two institutions opened the William 
H. Annesley, Jr., MD ’48 EyeBrain Center. It is the world’s 
first facility focused on exploring the visual signatures 
of neurological diseases—specifically, the connections 
between the retina and the optic nerve and disorders of 
the brain. 
Add to that its 15 specialty centers, including epilepsy, 
spine, sleep medicine, and the Jefferson Headache 
Center, and the neurosciences at Jefferson are opening 
up new frontiers in research, education, and patient care.  
With all the parts moving in unison, Tykocinski predicts 
advancements in the neurosciences will progress at a 
dizzying rate—including novel technologies for brain 
imagining, a greater understanding of molecular defects 
at the gene and protein levels, futuristic surgical and 
ultrasound therapies, and new immunotherapies. 
“The momentum is there,” he says. “And we’re going to 
keep that momentum by continuing to do unique, world-
class, cutting-edge kind of things that you’re just not 
going to find anywhere else.”  
To see a video featuring 
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”BEST HOSPITALS“
Vote!
U.S. News & World Report once again is surveying physicians 
across the country to  determine the reputation scores in the 
U.S. News & World Report “Best Hospitals” rankings. If you are a 
board-certified physician working within one of the U.S. News & 
World Report 16 specialties, vote for Thomas Jefferson 
University Hospital as among our nation’s Best Hospitals.
Look for your U.S. News & World Report survey invitation on 
Doximity.com in February/March. Doximity members can simply 
log on to their profile page, and click on the banner at the  
top that asks for nominations.
HOME OF SIDNEY KIMMEL MEDICAL COLLEGE
Thank you!
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t is September 26, 2018, and Jim McKenna is sitting 
on the edge of the exam table, waiting for the doctor 
to arrive. His left hand is shaking uncontrollably, 
his right hand only slightly less so. At today’s 
consultation, the 76-year-old will learn the details of 
his upcoming brain surgery. In spite of the somberness 
of the topic, McKenna has an upbeat attitude, a 
mischievous gleam in his eye, and a wickedly dry sense 
of humor. Even Parkinson’s disease can’t take that away 
from him. 
McKenna, from Warwick, Pennsylvania, will undergo 
deep brain stimulation (DBS) surgery in a few weeks to 
alleviate the ever-increasing symptoms of Parkinson’s 
disease—including tremors and stiffness—and he 
will do it under anesthesia. That’s not unusual for 
most surgeries, but it is for DBS, which is traditionally 
performed while the patient is awake. 
 
“Doing the surgery under anesthesia alleviates a lot 
of stress for the patients,” explains neurosurgeon 
Chengyuan Wu, MD, MSBmE, who will perform the 
operation. During DBS surgery, leads (wires with tiny 
electrodes) are implanted in a specific area of the brain. 
The leads are attached to a wire that runs under the 
scalp and beneath the skin of the neck, and is connected 
to a neurostimulator just below the collarbone under 
the skin. Like a pacemaker, the neurostimulator delivers 
electricity to the lead, which normalizes brain signals in 
the affected areas. This regulates the abnormal brain cell 
activity, and can greatly reduce symptoms.
Jefferson was among the first medical centers in the 
country to offer the asleep technique. 
“We strive to offer novel treatments and surgical 
techniques, complementary therapies, and pioneering 
research and clinical trials for our patients with 
Parkinson’s disease and other movement disorders,” says 
Daniel E. Kremens, MD, JD, co-director of the Movement 
Disorders Program.
Approaching neurological disorders from many 
different vantage points is what sets Jefferson apart 
from other institutions, says Richard J. Smeyne, PhD, 
director of Jefferson’s Comprehensive Parkinson’s 
Disease and Movement Disorders Center at the Vickie 
and Jack Farber Institute for Neuroscience – Jefferson 
Health. It has earned the Movement Disorders Center 
recognition from the Parkinson’s Foundation as a Center 
of Excellence, an elite designation reserved for just 34 
centers in the U.S. and 48 worldwide.
Jefferson’s three-year-old center, a nationally 
recognized facility for patients with Parkinson’s disease 
and Parkinsonism, dystonia, Huntington’s disease, 
tremors, ataxia, and tics or Tourette’s syndrome, received 
the designation in August 2019. Smeyne says that 
collaboration among all departments at Jefferson—both 
inside and outside the Vickie and Jack Farber Institute for 
Neuroscience—helped the center become the youngest 
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“Neuroscience is a multidisciplinary field,” says Smeyne, 
who received his PhD in neuroanatomy at Jefferson in 
1989. “It’s great to have all disciplines together under one 
umbrella so that you can have within one center all of the 
expertise and viewpoints you need for the full picture.” 
Viewpoints, he notes, are just as important as expertise, 
as seeing all the different sides of an issue—clinical, 
research, patient care—helps each participant better 
understand what is needed to accomplish a goal.
To that end, Smeyne takes his graduate students out of 
the lab, bringing them into the operating room to watch 
DBS surgery and into the clinic to observe movement 
disorders specialists working with patients. He also invites 
neurology and neurosurgery residents into the lab to 
conduct research. 
“We have four basic science labs here at Jefferson that 
are studying Parkinson’s disease, and we do not work in 
isolation. We are in constant communication with the 
clinicians, and they are in constant communication with 
us,” Smeyne says. “It’s a powerful program that really 
integrates what a true center of excellence is—not by 
thought, but by deed. After all, we are not here to solve 
Parkinson’s in mice—we are here doing work to better 
the condition of humans.”
THE PARKINSON’S JOURNEY
Jim McKenna’s Parkinson’s journey began six years ago 
when he noticed the telltale signs of the disease. First, 
his pinky began to twitch; then his arm began to tremor; 
eventually the involuntary and uncontrollable movements 
migrated to other parts of his body. As the symptoms got 
worse, he sought medical care with Kremens. 
McKenna began taking medication, and later signed up 
for Rock Steady Boxing, a noncontact exercise program 
that focuses on balance, strength, agility, motor skills, 
and flexibility for Parkinson’s patients. Over the past few 
years, clinical studies have shown that vigorous exercise 
is neuroprotective in animal models of Parkinson’s 
disease. The research into the effects of exercise on 
Parkinson’s began 15 years ago in Smeyne’s laboratory 
in the Department of Developmental Neurobiology 
at St. Jude Children’s Research Hospital in Memphis, 
Tennessee, and came with him to Jefferson.
“While we know exercise doesn’t cure the disease, recent 
studies have suggested that vigorous exercise might slow 
the progression, while other studies show that exercise 
can greatly improve quality of life,” Smeyne says. 
While the combination of medication, boxing, and other 
daily exercise helped McKenna for a while, as time wore 
on it became increasingly apparent he would need more. 
Kremens suggested DBS.
“What do you hope to get out of this surgery?” 
neurosurgeon Wu asks McKenna during the DBS pre-op 
visit.
McKenna thinks for a moment, 
looks at his trembling hand, and 
says, “I guess I shouldn’t expect 
to be able to put electrodes in 
someone’s head.”
“So your surgical career isn’t taking 
off right now?” Wu teases.
“Nah, it’s been a little slow,” 
McKenna shoots back. 
 
For all the joking and levity in the 
exam room, Parkinson’s is no 
laughing matter, and McKenna is 
pinning a lot of hope on the surgery. 
Of all the things DBS promises, the 
patient says the most important 
thing to him is simply to regain the 
ability to write. “I want to be able to 
sign my name again.”  
It’s a powerful 
program that really 
integrates what 
a true center of 
excellence is—not by 
thought, but by deed.
| Chengyuan Wu, MD, MSBmE, James (Jim) McKenna Jr. (son), and Jim McKenna
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“BECAUSE THERE WAS A NEED”
The Jefferson Movement Disorders Center was born 
out of the Movement Disorders Program, the brainchild 
of Abdolmohamad M. Rostami, MD, PhD, chair and 
professor of the Department of Neurology and director of 
neuroimmunology and the multiple sclerosis laboratory.
“Parkinson’s is a very common neurological disease,” says 
Rostami, explaining that, like many neurological diseases, 
Parkinson’s is a “disease of aging.” As the population ages, 
the need for care, specialists to administer that care, and 
research to find better ways to treat—and possibly cure—
the disease is central to the goal of his department.
The Parkinson’s Movement Disorders Program was created 
“because there was a need for it,” he says.
According to the Parkinson’s Foundation, more than 10 
million people worldwide are living with the disease. In the 
United States alone, approximately 60,000 are diagnosed 
with it each year. In addition, a recent study by the 
foundation predicts that by 2030, an estimated 1.2 million 
Americans will be living with Parkinson’s. 
“The disease affects about 2% of all people over 50 years 
old, and that’s only going to be getting greater as our 
healthcare gets better and people live longer,” Smeyne 
says, adding, “It is a disease that affects everyone. It knows 
no boundaries—not socioeconomic, religious, racial, or 
anything else.”  
In 2005, Rostami reached out to neurologist Tsao-Wei 
Liang, MD, and invited him to join the department; a 
few months later, Liang reached out to Kremens, who 
had completed a residency in neurology followed by a 
fellowship in movement disorders.
“It was an exciting opportunity to get in on the ground 
floor of something new,” says Kremens, a third-generation 
Jefferson Medical College (now SKMC) alum. 
Together, they built the program that would eventually 
lead to the creation of the center, providing care for an 
increasing number of patients. 
While the center treats those with a multitude of 
movement disorders, the majority of the patients have 
Parkinson’s, Smeyne says. “It is the second most common 
neurodegenerative condition in the world—just behind 
Alzheimer’s—and it’s growing fast.”
In the early days of caring for patients at Jefferson, 
Kremens and Liang became involved in clinical drug trials 
and device trials, eventually teaming up with Ashwini D. 
Sharan, MD, director of functional neurosurgery and the 
Neuroimplantation Center, to create a DBS program. Wu 
| Richard J. Smeyne, PhD
| Abdolmohamad Rostami, MD, PhD
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came a few years later, bringing with him the asleep DBS 
expertise. 
Soon, other pieces of the Movement Disorders Center 
puzzle began falling into place. The next step was 
to collaborate with those in basic science, including 
researchers such as Lorraine Iacovitti, PhD, who had 
been conducting studies in understanding how neurons 
differentiate into dopamine neurons during development 
of the brain.
The problem, says Kremens, was that the components 
were working independently of one another: “It was clear 
the departments needed to integrate.”
To do that, Jefferson recruited Smeyne, who had been 
studying the cell biology of Parkinson’s disease at St. 
Jude.
“He helped coordinate all the efforts—the clinical, the 
research both at basic level and clinical level, the patient 
care—bringing them all together. Once we had that, 
Jefferson designated us as a center,” Kremens says.
Throughout the years prior to the designation as a center, 
personnel were added, including a nurse practitioner, an 
administrative assistant, and a social worker. A fellowship 
program was established, and Jefferson’s neurology 
residency program grew to become one of the largest in 
the country, with 27 residents.
“It’s truly comprehensive in terms of neurology, 
neurosurgery, basic research, and rehab. We are focused 
on doing the work with the ultimate goal of helping the 
patient,” Smeyne says. “And that’s why we do everything 
we do—to help the patient.”
Currently, the components of the Movement Disorders 
Center are located in several places on the Center City 
campus, but future plans include expanding services 
and bringing everything under one roof—a kind of 
one-stop shopping center that would geographically 
bring together clinical services, rehabilitation therapies 
(physical, occupational, and speech), and research.
Care to Cure, a grassroots group of Movement Disorders 
Center patients and their families and friends, is 
spearheading fundraising efforts to help the new center 
become a reality—something Rostami says he is looking 
forward to.
“As quickly as we have grown, so has the list of patients 
waiting to be seen,” he says. 
HOPE AHEAD
In October 2018, McKenna underwent the three-hour 
DBS surgery; a month later, the physicians and nurse 
practitioner began the process of programming the unit. 
“DBS programming requires patience,” Kremens says. 
“Unlike what patients see on TV or the internet, where 
results often appear instantaneous after surgery, results 
from DBS can take up to six months of programming 
sessions. However, once the programming is completed, 
most patients need follow-up appointments only twice a 
year.”
By April 14, 2019—the sixth and final visit to tweak the 
programming—McKenna is more relaxed than in previous 
visits. With Sheila, his wife of 57 years, by his side in the 
exam room, he is pleased to report his progress. His 
tremors are greatly diminished. His gait is smoother. He is 
sleeping better. He is looking forward to spending time at 
his family’s summer home on Lake Champlain and taking 
the helm of his boat for the first time in four years. 
Six months later, at an October 9, 2019, visit to the 
doctor, McKenna reports that his summer was everything 
he had hoped it would be. The best part, he says, was 
being able to take his Zodiac out on the water while two 
of his grandchildren rode WaveRunners alongside him.  
“It was freedom,” he says of his ability to get back out 
on the boat. He is grateful for the care he receives at 
Jefferson that makes his progress possible—progress that 
includes being able to sign his name again.
McKenna knows the DBS surgery is not a cure. Neither 
is the medication. Nor the Rock Steady boxing. But all 
those things together have given him back much of what 
Parkinson’s robbed from him. And he is optimistic that 
ongoing research will provide breakthroughs that will 
continue to improve his life.
When asked what he would say to someone who just 
found out they have Parkinson’s, McKenna thinks for a 
moment, then smiles. “What would I say to them? I’d say 
there’s hope ahead.”  
     ...doing the work 
with the ultimate 
goal of helping the 
patient
To see a video featuring Jim McKenna, 
visit Jefferson.edu/Bulletin
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People
How One Doctor 
Helps Patients’ 
Voices Be Heard
BY  K A R E N  B RO O K S
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K
ristin Rising, MD, thought she was doing things 
the right way.
Early in her emergency medicine career, Rising 
would tell patients who lacked a clear diagnosis 
at the time of discharge that she had a lot of good news 
and a little bit of bad news—the good being that testing 
revealed no serious conditions, and the bad being that 
she didn’t know what caused their symptoms.
“It turns out that, from the patient perspective, this was 
often the worst news possible,” she says. “Diagnostic 
uncertainty can be intolerable for some people 
experiencing symptoms. A woman in one of my studies 
said she would rather be diagnosed with cancer than get 
discharged without an explanation. While this seemed 
unbelievable to me at the time, it is something that I 
have come to understand much better as it has been 
expressed by many others in different ways since.”
Rising, an associate professor of emergency medicine 
and director of acute care transitions, examines the 
drivers of recurrent emergency department visits and 
has found that uncertainty tops the list. Frustrated by 
those in the healthcare system who approach patient 
recidivism with a “shame on you” attitude and deem their 
returns inappropriate, she started asking patients what 
kind of support they needed to stay healthy outside of 
the hospital. 
“I hate that word, ‘inappropriate,’” she says. “Because 
it’s entirely relative to the perspective from which it is 
assessed. Any patient who comes back to the emergency 
department has made a decision that is appropriate for 
them considering their needs and resources. When a 
patient returns to the emergency department after a 
recent visit, I see it as a flag that the system is failing the 
patient. We need to figure out how we can fix the system 
to better assist people in having a safer transition home 
from their first ED visit, or in never needing to visit the ED 
in the first place.” 
As Rising surveyed returning patients, the same kinds of 
questions surfaced again and again, particularly among 
those who were discharged with a symptom-based 
diagnosis (such as “chest pain” or “abdominal pain”)—one 
out of every three ED visitors. Why aren’t my medications 
working? What else can I take? Is it safe for me to travel? 
Am I contagious? Is there a test you could have run, but 
didn’t? Will I still feel sick in a week? A month? A year?
“Not being able to plan and not knowing what to expect 
can be debilitating,” says Rising. She notes that some 
people report choosing the ED because they fear primary 
care physicians won’t have the tools to get quick enough 
answers: “If someone thinks they might have a brain 
tumor, they want immediate answers and think that the 
ED will have all the testing options they want.”
Since joining Jefferson in 2014, Rising—who earned her 
MD at the University of California San Francisco and has 
a master’s degree in health policy from the University 
of Pennsylvania—has received $5.6 million in research 
funding awards for which she is the principal investigator, 
and is currently leading or co-investigator on nine grant-
funded studies. Her research focuses on the design and 
redesign of the care delivery system to incorporate the 
unique circumstances and preferences of patients and 
their families. Rising has served on multiple national 
expert panels and is on the editorial boards for two 
journals. Her research has been funded by the National 
Institutes of Health, the Patient-Centered Outcomes 
Research Institute, the Agency for Healthcare Research 
and Quality, the Pennsylvania Department of Health, and 
multiple foundations.
One project funded by the Agency for Healthcare 
Research and Quality involves developing a checklist 
for emergency medicine residents to use with patients 
who have diagnostic uncertainty. The checklist improves 
communication with these individuals and helps 
clinicians manage their expectations and give explicit 
guidance for the days following discharge. Through prior 
funded work, Rising also developed the Uncertainty Scale 
(U-Scale), a tool to help quantify individual patient needs 
related to experiencing symptoms. The U-Scale helps 
identify different types of patient uncertainty, such as 
“symptom management” versus “financial implications,” 
which may benefit from different types of interventions.  
Although Rising initially resisted focusing her research 
on a specific disease, she has increasingly focused 
on patients with Type 2 diabetes, a condition she says 
exemplifies the disconnect between medical goals 
and patient goals. The year after she finished her 
undergraduate degree, she worked as a research assistant 
at San Francisco General Hospital and met a patient with 
poorly controlled diabetes and a chronic leg wound 
that just wouldn’t heal. While interviewing the patient to 
explore his barriers to staying healthy, he explained to 
“Not being able to 
plan and not knowing 
what to expect can 
be debilitating”
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Rising that the clinicians kept insisting that he stay off his 
leg and eat more nutritious meals—but he was homeless 
and spent his days searching for safe places to sleep and 
whatever food he could get. The man responded that he 
could not afford to rest, or to be picky. That encounter 
sticks with Rising to this day, nearly 20 years later.
“How could anyone argue with such a real and honest 
response?” she laments. “We have well-established, 
evidence-based treatments for diabetes, but they’re not just 
pharmacological, and success involves active participation 
from patients who might not have the foundation to carry 
out the ideal protocol. I want to know how we can better 
tailor interventions for these patients to meet their personal 
goals and get to better medical ends.”
Rising recently began a trial to determine just that, securing 
her largest funding award to date—a $3.3 million grant 
from the National Institute of Diabetes and Digestive and 
Kidney Diseases supporting a comparison of two different 
diabetes interventions focused on addressing social 
determinants of health. One group of patients will receive 
traditional care; a second will pair that same care with 12 
weeks of medically tailored meals delivered by the nutrition 
nonprofit MANNA; and a third will receive traditional care 
and MANNA meals while also participating in a telehealth-
delivered nutrition education program. This study includes 
a cost-effectiveness analysis, with the ultimate goal of 
influencing policy change to cover these interventions, if 
shown cost effective, as routine benefits. 
“We have some evidence from prior work that medically 
tailored meals are effective at improving outcomes for 
patients while also reducing costs, but it is not rigorous 
enough to inform widespread policy change. With this 
study, in which we will follow 600 patients for 12 months, 
I hope to show that the meals along with nutrition 
counseling lead to cost-effective and sustained change,” 
she says, adding that Aetna, Independence Blue Cross, and 
Health Partners Plans have all committed to considering 
expanding their benefits coverage based on the findings. 
“Patients have told us they don’t know enough about 
nutrition—that the healthcare system is good at telling 
them what not to eat, but not at telling them what to eat. 
They need to get a sense of how much food is OK and 
what a balanced diet looks like, and we can teach them 
that.”
Making sure patients’ voices are heard is among Rising’s 
greatest passions, but it’s not quite the greatest. That honor 
goes to her family: husband Louis and 2-and-a-half-year-
old twins Stella and Cora, whose wake-ups and bedtimes 
are her favorite times of day. A musician since childhood—
she played the violin, flute, and organ—she also started 
taking guitar lessons last winter in order to carve out some 
occasional “me time.”
Her daughters routinely sleep through the night, but Rising 
still lies awake sometimes, ruminating about her work—and 
how she can use it to improve healthcare delivery and 
change people’s lives. Her passion has been recognized 
in many ways, including with Jefferson’s Outstanding 
Research in Telehealth Award, which she has received three 
times, as well as the Marjorie A. Bowman, MD ’76, Early 
Career Investigator Award for Primary Care Research. The 
Pennsylvania Medical Society named her a Top Physician 
Under 40 in 2017.
“...my projects are all 
focused on patient 
engagement...”
Sidney Kimmel Medical College   41
“Sharon’s Daughter” 
K
ristin Rising, MD, can’t count how many 
times she’s met a fellow healthcare 
professional who exclaimed, “Wow—you’re 
Sharon’s daughter!”
Their awe makes sense, considering that Sharon 
Rising is a celebrated nurse-midwife who in the 
1990s developed a prenatal care model that has 
since been implemented in OB/GYN departments 
nationwide, including at Jefferson. Tired of 
rushing from exam room to exam room and 
having a mere 10 minutes with each patient, she 
began grouping women by due date for two-hour 
sessions during which they received care, and 
also built relationships and shared pregnancy-
related questions and concerns with each other. 
CenteringPregnancy, as Sharon Rising coined 
her approach, led to a 33% drop in preterm births 
compared to the traditional prenatal care system 
and has evolved into the Centering Healthcare 
Institute, an organization that also facilitates 
CenteringParenting and CenteringDiabetes 
programs.
“I grew up watching my mom doing this 
innovative care delivery, and then my dad was 
a crisis counselor and a minister who also had 
a strong focus on serving people in need,” 
Kristin Rising says. “Their efforts to identify the 
unique needs of underserved populations clearly 
influenced my path and helped me become the 
provider I am today.”
Rising’s vision is to establish a center to promote further 
development of her research portfolio through a 
multidisciplinary approach. The center’s goal would be to 
develop the rigorous evidence needed to build a health 
system truly capable of fulfilling each individual’s needs, 
including a focus on addressing the social determinants 
of health as part of routine healthcare. She would love to 
find an investor (or two) to launch the initial phases of this 
center, which she believes can be transformative to the 
way we approach healthcare delivery.
“What it comes down to is that my projects are all 
focused on patient engagement to inform a more 
patient-centered delivery system and address the social 
determinants of health,” she says. “We continually 
develop new, fancy medicines and push more medicine, 
more medicine, more medicine—but if we could just 
listen to patients and get to the foundation of what they 
need to be healthy on a daily basis, we would accomplish 
so much more.”  
People
Neal Flomenberg, MD ’76
2019 Alumni Achievement 
Award Recipient
Knowing the 
Half of It 
BY  K A R E N  B RO O K S
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There was once a man named Paul Revere who rode under the midnight moon. He knew he might never return, but he went riding, riding, riding—because he wanted a country without a king, a country 
where all men would be free.” These opening lines of 
Walt Disney’s Paul Revere, a children’s book about the 
famed silversmith’s journey to warn American patriots of 
incoming British troops on the cusp of the Revolutionary 
War, grabbed preschooler Neal Flomenberg instantly. 
Captivated by Revere’s fearlessness, but unable to read on 
his own, he made his mother repeat the story over and 
over until she became hoarse. 
“I was taken by Paul Revere’s courage and drawn to people 
who exhibited courage in real life. Even as a kid, I wanted 
to hang with people like him,” Flomenberg, MD ’76, recalls.
And, in a way, he does. As chair of Jefferson’s Department 
of Medical Oncology and director of the Blood and 
Marrow Transplant Program, Flomenberg treats patients 
who bravely face what he calls “some of the riskiest 
procedures a person can undergo.” His work to advance 
these procedures led to his recognition as the 2019 
Alumni Achievement Award recipient during SKMC Alumni 
Weekend in October.
If Flomenberg—a graduate of the joint Jefferson–Penn 
State accelerated medical degree program—had to credit a 
single date with charting his career trajectory, it would be 
September 13, 1979. That day, the “father of bone marrow 
transplant,” E. Donnall Thomas, MD, reported curing close 
to two-thirds of acute myelogenous leukemia patients 
who underwent transplantation when their disease was in 
chemotherapy-induced remission. Previously, transplant 
had been used only as a last-ditch effort in late-stage 
disease, with survival rates hovering around 15%. The 
publication had a profound effect on the field and on 
Flomenberg, a fellow in his first month on the bone 
marrow transplant unit at Memorial Sloan Kettering (MSK) 
Cancer Center in New York.
“Going forward, every transplant consult ended in tears—
one-third because there was this curative treatment and 
patients were lucky enough to have a family member who 
was a match, and the other two-thirds because there was 
this curative treatment, but it was not available to them 
because they didn’t have a match,” Flomenberg says. “We 
recognized quickly that we had to find ways to cross the 
matching boundary.”
“We” in this case included Flomenberg’s mentors, 
MSK pediatric oncologist Richard O’Reilly, MD, and 
immunogenetics researcher Bo Dupont, MD, along with a 
large number of MSK transplant team members. Together, 
they explored ways to transplant marrow from unrelated 
donors, as well as from donors who were not a perfect 
match.
Flomenberg continued these studies at Memorial 
Hospital for Cancer and Allied Diseases in New York and 
the Medical College of Wisconsin. He then returned to 
Jefferson, where he was charged with building a bone 
marrow transplant program from the ground up. He 
arrived in fall 1994 and spent his next birthday—September 
20, 1995—performing Jefferson’s first bone marrow 
transplant. By that time, a national registry of bone marrow 
volunteers was well established, but he still saw an urgent 
need to expand the donor pool.
“
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“Paul Revere got up 
on the horse and 
made the ride, but he 
couldn’t have pulled it 
off without his team.
“For reasons known only to God, people of African descent 
are much more diverse in terms of HLA [human leukocyte 
antigen, the cell surface markers used to match patients 
and donors for bone marrow transplants] background 
than Caucasians, so donors for these individuals were very 
limited,” he says. 
Institutions had been exploring half-matched bone 
marrow or stem cell transplants for blood cancer patients 
for years with largely disappointing outcomes. Results 
showed more promise, however, when a team from Johns 
Hopkins began administering one chemotherapy drug, 
cyclophosphamide, after transplant rather than before. 
When Flomenberg and his “right-hand person,” Dolores 
(Lori) Grosso, DNP, CRNP, heard the Hopkins clinician-
scientists present their findings at a meeting, light bulbs 
flashed in both of their heads.
“When you performed a transplant, you always gave both 
components of a graft at once: stem cells and T cells, a 
type of immune cell that fights infection,” Grosso says. “I 
was flummoxed because you didn’t give a specific dose of 
T cells and just took however many tagged along for the 
ride, even though T cells are so important.
“And now, we were concerned by this new idea because 
stem cells were being exposed to a chemotherapy drug 
that could harm them. Neal mentioned the possibility of 
splitting the procedure into two parts so the stem cells 
could remain untouched. It was a real ‘eureka!’ moment,” 
she remembers.
The colleagues conceptualized the first iteration of the 
protocol for a new two-step half-match procedure in 
the car on the way back to Jefferson. Their plan was for 
patients to receive chemotherapy or radiation before 
an infusion of donor lymphocytes that contained an 
optimized number of T cells to attack their cancer. A 
subsequent round of cyclophosphamide would then 
temper those T cells to curb graft–versus–host disease, a 
condition in which donated cells view the recipient’s body 
as foreign and turn against it. Next, patients would receive 
a donor’s hematopoietic stem cells, which would replenish 
their marrow and enable them to generate their own 
healthy stem cells within a matter of weeks.
“This was night-and-day different,” Flomenberg says. “We 
had started trying to deal with half-match transplants in 
the early 1980s and had struggled to make it consistently 
successful, and here we were putting our two-step 
program together in 2005.” They did their first transplant 
using this approach in 2006 and have performed nearly 
400 to date at Jefferson; success rates are on par with 
transplants from fully matched donors. 
Flomenberg refers to the procedure as “the equalizer,” 
since it puts transplant within reach for minority and 
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mixed-ancestry patients, many of whom lack a full match. 
A person has a guaranteed half-match in their parents and 
children. Moreover, while two siblings have only a 25% chance 
of being fully matched, they have a 75% chance of being fully 
matched or half matched and thus representing a viable donor.
The two-step protocol also benefits older patients, 
Flomenberg notes. “When I started, we never, ever, ever, 
did a transplant in someone over 40—that was considered 
advanced old age in our world. The oldest person we 
successfully transplanted here in our program was 77,” he 
says.
As he continues to refine bone marrow transplantation, 
Flomenberg, who became chair of medical oncology in 2008, 
puts just as much energy into leading his department. The 
administrative responsibilities can be draining, he admits, but 
time in the clinic leaves him revitalized.
“Neal can come in after some rough early-morning meeting 
about something tedious like our budget, but after a minute 
in a patient’s room, he is smiling,” Grosso says. “People tell me 
that when they are with him, they feel like they are his only 
patient. He remembers their families, their interests, what they 
do for fun. He gives them hope and the best possible care, but 
they give him something, too, and I think they can feel that he 
is drawing strength and energy from them.”
She recalls tearing up at the Eastern Pennsylvania Chapter 
of the Leukemia & Lymphoma Society’s 2019 Red & White 
Ball, where he received the Lifetime Achievement Award and 
dedicated it to his patients, several of whom he’d brought to 
the event as guests, along with his wife, Phyllis Flomenberg, 
MD, a professor of infectious diseases at Jefferson, and two of 
their three children.
As for Paul Revere: Flomenberg has been rapt by his heroic acts 
since childhood, but he is well aware that Revere did not work 
alone—and that he doesn’t, either.
“Paul Revere got up on the horse and made the ride, but he 
couldn’t have pulled it off without his team. There were the 
people who rowed him across Boston Harbor, the ones who 
set up the light signal in the church tower … in the kids’ version 
of the story, the family dog even played a role,” he says. “It’s like 
that with bone marrow transplant, which is the ultimate team 
sport in medicine. Let me be very clear: I could not do this 
work without Lori and the rest of our team.”
Then there are his patients’ teams. “The patients have to get 
up on the horse and undertake the ride, but their family and 
friends display a different kind of courage. In some respects, 
it can be easier to deal with your own problems than those 
of someone you really care about. My patients are inspiring, 
but the people around them are inspiring in a different way,” 
he says. “It is truly amazing what you can accomplish with the 
combination of courage and teamwork.” 
Study Group
If you want to work with Neal 
Flomenberg, MD, you’ll have to do 
your research.
That was among the first lessons 
Lori Grosso learned after joining 
Flomenberg’s bone marrow transplant 
team. A critical care nurse who 
thought she had signed on to work in 
the clinic, Grosso was stunned when 
she saw her name on a research 
protocol Flomenberg was sharing 
with colleagues. 
“I thought to myself, ‘This is not my 
work’—but in his eyes, the whole 
team should be doing research to 
help advance science and improve 
care for patients,” she says. “So I 
tried to participate and got really 
interested, and he became my 
mentor.”
Thanks to Flomenberg along with her 
own hard work and determination, 
today Grosso leads many of their 
program’s studies. In 2009, she 
completed her doctorate in nursing 
practice, a terminal clinical degree 
that Flomenberg nonetheless 
considered a credential for becoming 
a principal investigator. After she 
defended her capstone, he saw to it 
that she was promoted to research 
faculty member at SKMC.
“Neal was my cheerleader the 
whole way through. I am where I 
am because of him—everything he’s 
taught me and all of the opportunities 
he’s given me,” she says. “I thought 
he was a little crazy when I met him, 
but here we are, 23 years later, and 
I’m just as much of a research zealot 
as he is.”
46   Jefferson.edu/Bulletin







Sidney Kimmel Medical College   47
48   Jefferson.edu/Bulletin
T
here is a plaque in Hannah Garrigan’s bedroom, strategically 
placed so that it is the first thing she sees when she wakes 
up in the morning. It simply states: “Life begins at the end of 
your comfort zone.” It serves as both a reminder of what she 
has accomplished by pushing herself beyond boundaries, and 
encouragement for what she can achieve by continuing to do so.
“It’s been the theme of my life,” says the third-year Sidney Kimmel Medical 
College student. So far she has challenged herself to leave the security of 
her family and suburban Chicago home for college in Boston; to move to 
yet another unfamiliar city for medical school; to veer off of her previously 
planned-out path of high school–college–medical school–residency–work 
in favor of a gap year to study public health issues; and to trek across the 
globe to work with the underserved.
“I find that when I put myself in situations that are unfamiliar—that are 
uncomfortable—that’s when I grow the most,” Garrigan says.  
In the past year alone she has deviated twice from the route to becoming a 
doctor that she’s had mapped out since kindergarten: first, she put her last 
year of medical school on hold to pursue a Master of Public Health degree 
at Thomas Jefferson University’s College of Population Health, and second, 
she traveled halfway across the world to spend a month volunteering at an 
eye hospital in Hyderabad, India. 
“You just can’t predict where life is going to take you,” says the 26-year-old 
native of Oak Park, Illinois, who is planning a specialty in ophthalmology. 
“And that’s the fun part!”
But she wasn’t always so adventurous and open to the unknown. Growing 
up in an economically diverse suburb of Chicago, Garrigan carefully charted 
out each step of her life to achieve the dream of becoming a doctor.
LIFE BEGINS AT 
THE END OF YOUR 
COMFORT ZONE
“You know those elementary 
school posters that said, 
‘What do you want to be 
when you grow up?’ Mine 
always said ‘doctor,’” she 
says. “So I put myself on the 
straight and narrow path—do 
well in school, go to college 
in Chicago, then med school, 
then residency, then get a 
job…” 
But the self-proclaimed 
“homebody” found that 
pursuing her dream meant 
jumping off that straight 
and narrow path to follow 
the advice on her bedroom 
plaque. The first step away 
from her comfort zone was 
leaving Chicago to become a 
biology major (pre-med track) 
at Boston College. “I just had 
this realization in my senior 
year (of high school); I knew 
I had to push myself and 
not go along with what was 
safe,” she says. “I had this 
opportunity to go to Boston 
College and I took it.”
At first she was nervous 
about being alone in 
unfamiliar surroundings 
and felt overwhelmed by 
the difference between 
her outgoing and friendly 
Midwest ways and the slightly 
aloof Northeast attitudes: “It 
was a real culture shock. I 
was the weirdo in the hallway 
enthusiastically saying ‘Hi!’ 
to everyone and talking to 
people in the elevator.”
In time, she settled in, made 
friends, and started as a 
volunteer clinical researcher 
at Shriners Hospital for 
Children—Boston. After 
graduation, she again took 
a detour from her plans and 
spent a gap year at Shriners as 
a clinical research coordinator 
before applying to medical 
school—a move that brought 
into focus her reasons for 
wanting to become a doctor. 
“I realized watching the 
doctors there what it really 
means to be a doctor,” she 
says. “It’s being there for 
people when they’re lost and 
vulnerable, and connecting 
with them to make things 
better. That’s the incredibly 
special part of being a 
physician.”
When it came time to apply 
to medical school, she said 
the last place she expected to 
end up was Philadelphia. But 
when she visited SKMC, she 
fell in love with the “warm, 
welcoming environment” and 
the connection she felt with 
the students she met.
Although she was starting 
to see her dream become a 
reality, she had one major 
obstacle to overcome—her 
own apprehensions.
“I don’t come from 
generations of doctors 
like some of the students I 
met,” she says. “I’m from a 
blue-collar family—it was 
really intimidating to feel so 
different. I constantly had to 
remind myself I am worthy of 
this.”
Jefferson agreed, not only 
inviting her to join the 
class of 2020 (now 2021), 
but awarding her the Liss 
Scholarship for three years 
straight. 
The scholarship was 
established by Amy Liss and 
her late husband, Henry Liss, 
MD ’48, almost 30 years ago 
for outstanding students with 
financial need. Garrigan says 
she was thrilled to travel to 
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| Garrigan with patients at LV Prasad
| Garrigan and her mentor, Dr. Anthony Vipin 
Das, at LV Prasad
| Garrigan dines with Dr. Vipin and his wife, Dr.  
  Deepti Raj, a family medicine physician, at a     
  traditional South Indian restaurant 
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the Summit, New Jersey, home 
of her 88-year-old benefactor, 
in August 2019 to thank her in 
person. 
“I honestly can’t thank her enough. 
I would not be where I am today 
without people like her,” Garrigan 
says, explaining that the rising 
cost of medical education and 
the expense of living in Center 
City can be overwhelming. “Her 
kindness and support mean a lot 
to me on both a financial and an 
emotional level.”
At the end of her first year of 
medical school, she was given the 
opportunity to pay forward that 
kindness and travel to Nicaragua 
with Jefferson’s chapter of Global 
Brigades. The international 
organization consisting of students 
and medical professionals works in 
remote, rural, and under-resourced 
communities in Honduras, 
Panama, Nicaragua, and Ghana 
to implement sustainable health 
systems.
At first, she was hesitant. “I 
wanted to do it, but I thought to 
myself, ‘Just stay in the lane, be 
comfortable, follow the path.’” But 
at the constant urging of a friend, 
she relented, and spent a week 
working with a group of physicians 
delivering medicine, running 
clinics, and helping with manual 
labor in a small village.
“It was an incredibly life-changing 
experience,” she says. “It was 
something I didn’t anticipate, but 
something I needed to do.”
Another experience that 
unexpectedly altered her life was 
an ophthalmology rotation. She 
originally planned on a career in 
internal medicine; however, all that 
changed after a short time on the 
ophthalmology service of James P. 
Dunn, MD, director of the Uveitis 
Unit at Wills Eye Hospital. After 
a lengthy conversation with him 
about the specialty, Dunn invited 
Garrigan to spend a month-long 
rotation with him. She was sold—
ophthalmology had everything she 
was looking for in medicine. 
By her third year of medical 
school, Garrigan was getting used 
to the idea of diverting from her 
original plans, and decided to take 
a giant leap from her comfort zone 
after reading Michelle Obama’s 
memoir, Becoming. 
In the book, the former first lady 
writes about a friend who took “a 
swerve”—putting his professional 
studies on temporary hold to 
pursue a long-held dream of 
serving as a sports team’s mascot. 
“I wanted to do my own kind of 
swerve,” Garrigan says. “I read the 
book and asked myself, ‘Do I need 
to rush into residency or should 
I take some time to develop as a 
human being, as an intellectual? 
Do I want to explore a plan B?’”
After working diligently in school 
from first through 12th grade and 
graduating among the top in her 
class, cramming for the MCAT, and 
plugging away in medical school 
for three years, she decided it 
was time for a break to pursue a 
plan B—completing a 10-month 
program for a master’s degree in 
public health.
“An MPH gives you this lens into 
medicine that’s different from the 
view you get in med school,” she 
says. “It opens up new avenues 
in policy and advocacy, ethics, 
quality and safety, and analytics 
that add to your overall education.” 
The MPH swerve led to another—
in December 2019, she traveled 
to India to volunteer at the LV 
Prasad Eye Institute in Hyderabad, 








| Garrigan visits with Amy Liss
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research, working with patients, and 
studying public health initiatives. 
The opportunity arose out of 
the blue when she mentioned 
her interest in global health, her 
experience in Nicaragua with 
Global Brigades, and her desire to 
pursue ophthalmology, to Rosie 
Frasso, PhD, MSc, MSc, CPH, 
the program director of Public 
Health at the Jefferson College of 
Population Health. 
By coincidence, Dr. Frasso had a 
meeting scheduled with people 
from India who were visiting 
Jefferson for the 19th Annual 
Population Health Colloquium. One 
of the ophthalmologists from India, 
Dr. Anthony Vipin Das, presented at 
the event.
“All of a sudden, we’re meeting with 
someone and I’m invited to India 
to work on public health initiatives 
and the delivery of care,” Garrigan 
says. While Jefferson has hosted 
students from India, Garrigan is 
the first student from Jefferson to 
travel to India to work at the eye 
hospital. 
Today, Garrigan’s original straight 
and narrow path to her dream of 
becoming a doctor looks more like 
a long and winding road. And that’s 
OK with her.
“If I’ve learned anything these past 
few years, it’s that you can’t predict 
the future. You can plan, but the 
world is so dynamic that you have 
to be open-minded to changes 
and accept that it’s OK to not know 
where you’re going,” she says. 
As for her future? Garrigan says 
she’s constantly—and pleasantly—
surprised by what happens. 
“You just have to be open to 
where life takes you in this crazy 
world and know that opportunities 
present themselves in weird ways, 
and you can either take them or 
not,” she says. 
She does know one thing for sure—
she will keep stepping outside of 
her comfort zone and taking those 
opportunities. After all these years, 
the advice on that plaque in her 
bedroom hasn’t steered her wrong 
yet.  
To see a video featuring Hannah Garrigan, visit  
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| An evening out to visit the iconic  
  Charminar in Hyderabad 
| In the operating theater with Dr. Sunita  
  Chaurasia, cornea and anterior segment  
  specialist at LVPEI 
There are no green jackets or golf clubs to be found among the masters at Jefferson. Instead, you’ll find white coats, stethoscopes, and a group of doctors who have dedicated their lives to 
furthering the field of internal medicine.  
Mastership is the highest honor that can be bestowed 
upon a physician by the American College of Physicians 
and is a testament to a doctor’s contributions to and 
achievements in the field of internal medicine. Masters 
have earned recognition as industry leaders and are often 
viewed as the physician’s physicians.
Looking Back, Moving Forward
To understand the place of the master in the future of 
healthcare, it’s important to understand its role throughout 
history. 
Positioned between the tail end of the Renaissance and 
the advent of the scientific revolution, the 16th century 
was a period of economic prosperity, artistic expression, 
and scientific discovery. Yet, the “physicians” of the time 
were often killing as many people as they saved. In an 
attempt to distance themselves from the plague doctors, 
“balancing of humors,” and bloodletting of old, a group 
of physicians—led by scholar Thomas Linacre—gathered 
together to legitimize medical practice and education in 
England.
of the 29 active 
masters practicing 
in Pennsylvania 
today, 5 internists 
call Jefferson 
home.
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The Royal College of Physicians (RCP)—
originally just the College of Physicians—
was established in 1518 by King Henry 
VIII to raise the standard of healthcare. 
The RCP is the oldest medical college 
in England and still plays a major role in 
public health, medical education, and 
research in the United Kingdom and 
throughout the world.
The American College of Physicians 
(ACP) draws on influences from the 
RCP after Dr. Heinrich Stern—German-
born physician and eventual founder 
of the ACP—attended a conference 
in England in 1913. That conference 
convinced him that it was vital to have 
a similar institution stateside; two years 
later, the ACP was established with the 
mission to “enhance the quality and 
effectiveness of healthcare by fostering 
excellence and professionalism in 
the practice of medicine.” With nearly 
160,000 members, the ACP is the largest 
medical-specialist society and second-
largest physician group in the country. 
Since its inception, the ACP has served 
in an educational and advocacy role for 
U.S. internal medicine physicians and 
their patients. 
There are several levels of membership 
in the ACP: medical student, associate, 
member, fellow (FACP), and master 
(MACP). To become a fellow, a member 
must be recognized by their peers and 
endorsed by their local chapter, and have 
their credentials reviewed by a national 
subcommittee. Masters are recognized 
for their continued excellence through 
scholarly inquiry, publications, 
leadership, and dedication to the field of 
internal medicine. 
Jefferson Masters
Of the 29 active masters practicing in 
Pennsylvania today, five internists call 
Jefferson home. As with all masters 
of the ACP, these Jeffersonians were 
elected to the level of master because 
of their “integrity, positions of honor, 
eminence in practice or medical 
research, or in attainments in science or 
the art of medicine.” 
Mastership at Jefferson is nothing new. 
Willis Maddrey, MD, who sat as chairman 
of the Department of Medicine from 
1982 to 1990 and served as president 
of the ACP from 1992 to 1993, was 
elected to mastership in 1993. Thomas 
Nasca, MD ’75, the former dean of 
Jefferson Medical College (now Sidney 
Kimmel Medical College) and CEO of 
the Accreditation Council for Graduate 
Medical Education (ACGME), became a 
master in 2006. Two more Jeffersonians 
joined the ranks in 2013 when both Drs. 
Howard Weitz, MD ’78, MACP, FACC, 
FRCP (Lond.), and Geno Merli, MD ’75, 
MACP, FHM, FSVM, were elected to the 
rank of master.
Dr. Weitz, the Bernard L. Segal Professor 
of Clinical Cardiology, has spent decades 
advocating for ACP’s educational 
mission. For more than 20 years, Weitz 
has contributed to the Annals of Internal 
Medicine, the ACP’s flagship publication, 
which is the most-cited general medical 
journal in the world, and served as a 
long-term associate editor for the ACP’s 
Medical Knowledge Self-Assessment 
Program, a resource physicians use to 
keep up to date with internal medicine 
and its subspecialties. 
“It’s an amazing acknowledgement for 
us to be among the less than 1% of all 
fellows to be recognized above the 
crowd,” Weitz says of mastership. “We 
feel this responsibility to uphold the duty 
of elevating the field of internal medicine 
and, in doing so, enhancing the care for 
patients in America.”
Dr. Merli, senior vice president and 
associate chief medical officer at 
Thomas Jefferson University Hospital, 
co-director of Jefferson Vascular Health, 
and the division director of vascular 
medicine in the Department of Surgery, 
is a nationally recognized expert in 
the prevention and management of 
deep vein thrombosis and pulmonary 
embolism. Dr. Merli is both a contributor 
and a dedicated reviewer for Annals of 
Internal Medicine.
“It’s an acknowledgement that our focus 
at Jefferson is education,” Merli says. “It 
recognizes that we spend time investing 
in the careers and training of our future 
physicians and healthcare leaders.”
Howard Weitz, MD ’78
Geno Merli, MD ’75
The Consult Guys
Both Drs. Weitz and Merli—who 
have been friends for more than 
40 years—are Jeffersonians 
through and through. They are 
both graduates of Sidney Kimmel 
Medical College and have each 
spent their entire professional 
careers at Jefferson.
While both are accomplished 
doctors in their own right, the 
tag-team duo has been a force 
in bringing the ACP’s educational 
mission to audiences around the 
world for more than 20 years.  
Now, Weitz and Merli are known 
among the ACP community for the 
“Consult Guys”—their monthly web 
series that mixes medical education 
with a healthy dose of humor. 
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The next Jeffersonian master 
designation came in 2018, when 
Gregory C. Kane, MD ’87, MACP, the 
Jane and Leonard Korman Professor of 
Pulmonary Medicine and chairman of 
the Department of Medicine at Sidney 
Kimmel Medical College, was elevated 
to master in the ACP. Currently, Dr. 
Kane sits as the treasurer of the ACP, 
and is the immediate past-governor 
and local membership chair for the 
Southeastern Pennsylvania Region 
chapter of the ACP. 
“The unique position of Jefferson 
with three masters in medicine and 
two in medical oncology underscores 
Jefferson’s commitment to strong 
clinical education and patient-centered 
care,” Kane says. “It reflects Jefferson’s 
national reputation for excellence in 
clinical care.”
In 2018, Ana María López, MD ’88, 
MPH, MACP, professor and vice 
chair of medical oncology at Sidney 
Kimmel Medical College and chief 
of the New Jersey Division of Sidney 
Kimmel Cancer Center, was also 
elevated to the level of master. Dr. 
López is the immediate past president 
of the ACP and served as chair of the 
Ethics, Professionalism, and Human 
Rights Committee and governor of 
the Arizona chapter of the ACP. Dr. 
Lopez’s passion and commitment are 
to improve care, to improve access, 
and to improve outcomes. Dr. Lopez’s 
clinical expertise is in women’s cancer 
and integrative oncology. Her research 
has focused on cancer health equity, 
symptom management, and access to 
care, and employs novel technologies 
and innovations in care delivery. 
Dr. López notes; “I joined ACP as a 
resident. It was one of the ‘must-dos’ 
that Dr. Maddrey, the chair of internal 
medicine when I was a student, 
recommended, and like his other 
words of wisdom, they were right on 
the mark! The ACP is a community and 
what binds us together—globally—is 
our commitment to our patients. ACP 
policies and efforts hold the patient as 
the North Star. Sharing this passion with 
colleagues is an honor of a lifetime.”  
Most recently, Edith Peterson Mitchell, 
MD, FACP, FCPP, the director of the 
Center to Eliminate Cancer Disparities, 
was welcomed into the ranks of 
ACP masters. Dr. Mitchell has been a 
trailblazer for women and minorities 
in the medical profession, as well as 
a champion for underrepresented 
populations in her battle against 
inequity in healthcare. Throughout her 
storied career, Dr. Mitchell was the first 
female physician to achieve the rank of 
brigadier general in the U.S. Air Force, 
the first female medical oncologist 
to serve as president of the National 
Medical Association, and the first black 
woman to receive Thomas Jefferson 
University’s Academician of the Year 
and PHL Life Science’s Ultimate 
Solution Award. In 2019, Dr. Mitchell 
was elevated to the level of master in 
the ACP. 
“As there is a continuously increasing 
minority population in the United 
States, it is important to apply 
precision medicine standards and 
know differences in prevention, 
diagnoses, and appropriate therapeutic 
interventions,” Mitchell says. “Moreover, 
it is also important to increase diversity 
in the pipeline of trainees in internal 
medicine and its subspecialties to 
match the percentage representation 
of minorities in the population.”
With backgrounds in cardiology, 
vascular medicine, pulmonary 
medicine, and medical oncology, the 
masters at Jefferson bring together a 
wealth of knowledge and experience 
from their subspecialties. Each master 
still believes it’s essential to approach 
patients with the mindset of a general 
internist and treat each patient 
comprehensively, and that is part of the 
reason they consider mastership such 
an honor.  
The Future of the Master 
Clinician 
Since the first master, Dr. James M. 
Anders, was elected to the ACP in 
1923, the medical field has drastically 
changed and the role of the master 
clinician has changed alongside it. 
Gregory C. Kane, MD ‘87
Ana María López, MD ’88
Edith Peterson Mitchell, MD
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  “A Toast to the Queen”
In September 2019, Dr. Weitz achieved another milestone when he was elected as a fellow of the Royal College of Physicians (RCP) of London.
In 2016, the RCP started a joint program with the 
American College of Physicians to share resources 
and nurture the common goals of both colleges. 
Each year, 25 physicians who have reached the high-
est level in their institution are nominated to receive 
a fellowship within the partner organization. Dr. 
Weitz, one of five current ACP masters at Jefferson, 
is the first within the university to achieve this new 
honor. 
Of the nearly 160,000 members of the ACP, less than 
1% have been designated as masters. Since 2016, the 
RCP has elected approximately 5% of ACP masters as 
fellows of the RCP.
Dr. Weitz was elected to the RCP based on his re-
search on the identification and reduction of risk for 
patients with heart disease who undergo noncardiac 
surgery, his contributions to the ACP, and his com-
mitment to the continued medical education of the 
next generation.
“Jefferson lives the life of the patient-focused, 
patient-oriented medical school and academic 
healthcare center,” Weitz says. “We put so much 
effort into focusing on the knowledge, the teaching 
of the students in terms of science, and a humanistic 
approach to the patient.”
Dr. Weitz’s contributions to the field of cardiology 
and medicine, and his commitment to training the 
next generation of master-class physicians, can’t be 
overstated. Dr. Weitz’s recognition as an American 
master and a British fellow demonstrates his—and 
Jefferson’s—dedication to becoming a force for 
good and reimagining the future of healthcare for 
patients around the world.
Historically, the master was a “groundedly learned” 
physician with a photographic memory who could 
make a quick, accurate diagnosis, but whose 
bedside manner left something to be desired. In 
the modern era—thanks to advances in technology 
and access to information—the role of the master is 
changing once again. 
There’s no denying that accurate identification and 
timely treatment are still vital requirements, but 
the master clinician now needs to view patients 
as more than simply a disease and a diagnosis. 
Physicians now have the entirety of the National 
Library of Medicine at their fingertips, and 
establishing a trusting patient-physician relationship 
and treating a patient holistically are of growing 
importance in the master clinician’s skill set. 
As a master himself and a senior associate dean 
of Sidney Kimmel Medical College, Dr. Weitz 
understands the need to keep the patient-
physician relationship paramount, and is building 
an educational program for young faculty and 
physicians so they can sustain and grow their 
connection to patients in an ever-changing 
healthcare landscape.
 
“It has to come out of Jefferson, because Jefferson 
lives the life of the patient-focused, patient-
oriented medical school and academic healthcare 
center,” Weitz says. 
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Nicholas J. Ruggiero II, MD ’01, 
FACP, FACC, FSCAI, FSVM, FCPP
Director, Structural Heart Disease and 
Non-Coronary Interventions
Director, Jefferson Heart Institute 
Vascular Laboratory
Associate Director, Cardiovascular 
Diseases Fellowship
Associate Professor of Medicine,
Sidney Kimmel Medical College
President, Sidney Kimmel Medical 
College Alumni Association
Dear Fellow Jeffersonians,
The SKMC Alumni Association had the great honor of 
holding the 2019 SKMC Alumni Weekend at the close 
of this last October. SKMC alumni who graduated with 
class years ending in 4 and 9 reunited, reconnected, and 
reminisced over our history with our beloved alma mater. 
In attendance was Mark L. Tykocinski, MD, provost and 
executive vice president for academic affairs for Thomas 
Jefferson University and the Anthony F. and Gertrude 
M. DePalma Dean of Sidney Kimmel Medical College. 
Dr. Tykocinski chatted with our fellow Jeffersonians and 
shared his keen insight on where we have been and where 
we are going.
Amid the good times and cheer, we were honored 
to present the Alumni Achievement Award to Neal 
Flomenberg, MD ’76, professor and chair of the 
Department of Medical Oncology and director of the 
Blood and Marrow Transplant Program at Thomas 
Jefferson University Hospital. The gathered alumni were 
also privileged to confer the Distinguished Alumni Award 
on Jonathan Letterman, MD 1849, the medical director for 
the Army of the Potomac during the American Civil War 
and the “father of battlefield medicine.”
At the Pinizzotto-Ammon Alumni Center, the Rieders 
Family Alumni Art Gallery rang in its inaugural exhibit 
with the watercolors of Gerald Marks, MD ’49. Dr. Marks’ 
paintings brought to life yet another Jefferson story, 
one that traces a vibrant journey from Philadelphia to 
Paris, Rome, and beyond, chronicling Marks’ travels as 
an educator and pioneering surgeon. The Rieders Family 
Alumni Art Gallery features rotating exhibitions of art 
from alumni, and submissions are open for future shows. 
We invite you to contact Louisa Kopp at louisa.kopp@
jefferson.edu or 215-955-2171 to learn more.
In our commitment to preserve our past, the association’s 
Strategic Initiatives Committee has embarked on creating 
an oral history of Jefferson from the alumni perspective. 
We’ve enlisted the help of university archivist and special 
collections librarian F. Michael Angelo, MA, and have 
already collected a range of powerful stories from 
alumni, including those of Victor Greco, MD ’51, who 
was Muhammad Ali’s personal physician and took part in 
the first successful open-heart surgery using the Gibbon 
heart-lung machine. Beyond tales of the past, Dr. Greco 
shared stirring words of wisdom for the medical students 
of today and tomorrow. If you are interested in preserving 
your Jefferson stories with the project, please reach out to 
the Alumni Office at alumni@jefferson.edu so that we can 
schedule a session.
Here at the SKMC Alumni Association, we are forging 
ahead with new programs, and we’re always thrilled to 
hear from our alumni. You can reach out to me or Cristina 
Geso, associate vice president of Alumni Relations, at 
cristina.geso@jefferson.edu or 215-955-7750 with any 
questions or concerns. Jeffersonians are a spirited, 
engaged group, and it’s that spirit and engagement that 
guarantees not only the vitality of our events, but the 




Keep up with the latest and greatest goings-on at Jefferson 
with our monthly university e-newsletter, which features news, 
articles, and events you won’t want to miss!
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1. Elizabeth Schroeder Bussard, 
MD ’69, Frederick Ifft, MD ’69, 
and Suzanne Zeok, MD ’69, visit 
the photo booth during the 
Welcome Reception.
2. Thomas Moore, MD ’84, and 
Susan Moore.
3. Michael Ginieczki, MD ’69, 
Michele Ginieczki, John Schiro, 
MD ’69, SKMC Alumni Board 
& Alumni Awards Committee 
chair M. Dean Kinsey, MD ’69, 
Jonathan Kaplan, MD ’69, and 
Karen Kaplan gather during the 
Dean’s Luncheon and Alumni 
Awards Presentation.
4. Nivedita Chander, MD ’94, 
and Suprith Badarinath, MD ’94.
5. The class of 1994 celebrates 
a joyful 25-Year Reunion at the 
Reunion Dinner.
6. Evans Webb, Elizabeth Webb, 
MD ’69, Linda Weinberg, MD ’69, 
and Paul Weinberg, MD ’69.
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On October 25 and 26, Jefferson 
celebrated the 4s and the 9s as SKMC 
alumni from 1949 to 2014 returned 
to their alma mater to reconnect with 
old friends, reminisce on their days as 
medical students, and revisit their old 
stomping grounds.
This year, the class of 1969 was 
officially welcomed into the prestigious 
50-Year Society. Celebrating the 
50th anniversary since graduating 
from Jefferson, this milestone is 
commemorated with a special alumni 
pin and an exclusive reunion ceremony.
7. SKMC Alumni Board member Galicano Inguito, MD ’90, and son, Kai Inguito, 
SKMC class of 2022.
8. SKMC Dean Mark L. Tykocinski, MD, M. Dean Kinsey, MD ‘69, Neal Flomenberg, 
MD ‘76, and SKMC Alumni Association president Nicholas Ruggiero, MD ’01, at 
the Dean’s Luncheon and Alumni Awards Presentation, during which Dr. Kinsey 
presented Dr. Flomenberg with the Alumni Achievement Award.
9. Alan Schein, MD ’69, Caren Schein, Linda Weinberg, MD ’69, and 
Paul Weinberg, MD ’69.
10. K. Ellen Frank, MD ’69, and Elizabeth Schroeder Bussard, MD ’69, celebrate their 
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“It’s great to see the growth of 
Jefferson over the past half century. 
The campus is much bigger and has 
a real campus feeling. It was really 
nice catching up with many people 
that I haven’t seen in years.”
– Jay Skyler, MD ’69     
11. M. Dean Kinsey, MD ’69, 
presents the Reunion Giving 
Campaign check to Dean 
Mark L. Tykocinski, MD.
12. Thomas Stephens, Mary 
Stephens, MD ’94, Jean 
Rosenbaum, and Robert 
Rosenbaum, MD ’94.
13. Jay Skyler, MD ’69, and 
Mercedes Skyler pose for a 
photo at the Reunion Dinner.
14. Ramon Molina, MD ’59, 
receives his 50-Year Society 
pin with Nicholas Ruggiero, 
MD ’01, Mark L. Tykocinski, 
MD, and Elizabeth Dale.
15. Gerald J. Marks, MD ’49, 
and Mercedes Skyler, wife of 
Jay Skyler, MD ’69, discuss 
his portfolio of artwork 
displayed in the inaugural 
exhibit of the Rieders Family 
Alumni Art Gallery.
16. The class of 1969 
celebrates its 50-Year 
Reunion while posing for 











17. The 40-Year Reunion class gathers for its class photo during the Reunion Dinner.
18. Steven Kazenoff, MD ’79, and Sonya Kazenoff at the Loews Philadelphia Hotel 
during Saturday evening’s Reunion Dinner.
19. Mahesh Krishnan, MD ’94, and Jeffrey Chao, MD ’94, mingle with current medical 
students during the Jefferson-Penn State Alumni Reunion in Jefferson Alumni Hall.
20. The class of 1984 joins together for its 35-Year Reunion at the Reunion Dinner.
21. Mike Chen, MD ’06, and Rupal Chiniwala, MD ’94, take time to meet with future 








Don B. Knapp, II says, “I closed my 
ophthalmology practice in April 2019 
and retired after 46 years in the same 
location as a sole proprietor.”
’65
J. Dennis Steen has retired from 
actively practicing ophthalmology, 
after having practiced in Kentucky 
from 1972 to 1981 and in California 
from 1981 to 2010. He says, “My 
wife, Betsy, and I are now full-
time residents in Arizona, building 
our new home in the Preserve at 
SaddleBrooke.”
’67
Elliot J. Rayfield’s endowed 
scholarship has reached its goal. 
The “Class of 1967” scholarship 
was launched with a gift from Dr. 
Rayfield on November 18, 2009. 
During SKMC Alumni Weekend 
2019, a gift was made that pushed 
the scholarship fund to its $100,000 
goal.
’69
Suzanne Springer Zeok, MD, ’69, and 
John V. Zeok, MD, ’67, established 
the Springer-Zeok Scholarship at 
Sidney Kimmel Medical College in 
2019 in celebration of their 50th 
Jefferson graduation anniversary 
and their 50th wedding anniversary. 
Their $100,000 gift to create the 
scholarship was matched at $50,000 
by the Keller-Gonnella Endowment 
matching program.
’74
John P. Lubicky says, “I turned 70 
on September 23 (same birthday as 
Bruce Springsteen). Still working full-
time as chief of pediatric orthopaedic 
surgery at West Virginia University. 
Hoping to hold on until our new 
children’s hospital opens in June 
2021!”
’76
Kenneth W. Sommerville says, “I was 
blessed to have a satisfying career 
as a practitioner in neurology before 
joining the pharmaceutical industry. 
In that career, I was involved in 
developing multiple drugs for various 
conditions, primarily in epilepsy.”
’81
Richard F. Spaide recently gave the 
103rd Annual Doyne Medal Lecture 
at Oxford University. In addition, he 
was made a fellow of the Association 
for Research in Vision and 
Ophthalmology; received the Jack 
Guyton Lectureship Award at Henry 
Ford Hospital and the European 
VitreoRetinal Society Award in 
Prague; and was the Paul A. Chandler 
Visiting Professor at Massachusetts 
Eye and Ear, Harvard University. 
A comprehensive rating of 7 million 
scientists around the world in 22 
fields and 176 subfields in science 
was done by John Ioannidis, MD, 
DSc, at Stanford University (PLOS 
Biology, August 2019). The research 
work rated the scientific impact 
of research publications by the 
scientists. Dr. Spaide had special 
recognition in that he was in the 
top 0.01% of scientists—he was 
rated 677 out of the 7 million. He 
was the second-highest-rated 
ophthalmologist in the report.
’82
Joseph P. Walls says, “After 
graduation from Jefferson and 
an orthopaedic residency at the 
Medical College of Virginia, I served 
four years active duty in the U.S. Air 
Force. That included an eight-month 
deployment to the Middle East 
during Desert Storm. Upon leaving 
the Air Force, I finished a fellowship 
at Penn State University. After 26 
years in private practice in Carson 
City, Nevada, I retired from my 
practice in 2018. 
“I enjoyed downhill skiing, scuba 
diving, and animal rescue during 
that time. I now participate in an 
orthopaedic clinic once each 
month for the state of Nevada. My 
new endeavor is as a volunteer 
on-air disc jockey at a local radio 
station, KNVC, on a show called 
‘Your Music Prescription with Dr. J.’ 
You can stream the music show on 
Wednesday afternoons from 4 to 
7 p.m. East Coast time, 1 to 4 p.m. 
West Coast time at www.knvc.org by 
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clicking the ‘Listen Live’ button on top 
of the screen. There is a new theme 
each week.”
’85
Guy Hewlett was appointed assistant 
dean of diversity affairs at Cooper 
Medical School of Rowan University in 
September 2019.
’90
Mohan Suntha was named president 
and CEO of the University of Maryland 
Medical System in November 2019. 
Prior to the new role, he has held 
positions as president and CEO of the 
University of Maryland Medical Center, 
and president and CEO of University of 
Maryland St. Joseph Medical Center.
’92
Michael Angelis says, “I have 
performed over 1,000 abdominal 
transplants (liver, pancreas, kidneys) 
since joining AdventHealth Medical 
Group Transplant at Orlando in 2003.”
’08
Aimee Ostick opened Health 
and Healing Direct Primary Care 
in Woodland Hills, California, on 
September 1, 2019. Dr. Ostick is excited 
to offer high-quality and affordable 
primary care to the local community 
she lives and works in. She considers 
direct primary care a way to both 
address physician burnout and reduce 
the incredible expense of our United 
States healthcare industry.
’13
Tara Spencer (Hennig), class of 2013, 
and Morgan Spencer, class of 2015, 
were married on November 4, 2018. 
They celebrated their first wedding 
anniversary this past November.
SMART INVESTING. 
“Jefferson’s IRA rollover 
program offered me a simple 
way to give back to my alma 
mater. They condensed a 
complicated process into one 
step, helping me to save on 
my taxes and support a great 
community resource.”
—Leonard A. Erdman, MD ’50
How it works
• You must be age 70½ or older at the time of your gift.
• The gift must be made on or before December 31 
for the 2019 tax year.
•  Transfers must be made directly by your IRA 
administrator to Jefferson.
•  Gifts must be outright. The rollover must be from 




•  You can transfer up to $100,000 annually from your IRA to 
Jefferson; spouses can each transfer up to $100,000.
• Rollovers are free of federal tax.
•  Rollovers qualify for your “required minimum distribution” 
for the year.
• You can reduce your taxable income, even if you do not 
itemize deductions.
• You can designate your gift to any area or program 
at Jefferson.
SMART GIVING.
Now, more than ever, your required 
minimum IRA distribution can make 
a difference—for you and Jefferson.
To learn about making a gift through your IRA and other planned giving opportunities, contact:
Lisa W. Repko, JD
Vice President, Thomas Jefferson University and Planned Giving
lisa.repko@jefferson.edu  |  215-955-0437
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Class Agent
Bernard L. Lopez, MD ‘86
Associate Provost, Diversity and Inclusion
Associate Dean, Diversity and Community Engagement
Professor and Executive Vice Chair, Department of 
Emergency Medicine
Sidney Kimmel Medical College at Thomas Jefferson 
University
Jefferson graduate, class of 1986. A residency in 
emergency medicine at Thomas Jefferson University 
Hospital right after. Affiliate faculty in the Department 
of Emergency Medicine for three years after residency 
while I worked at Brandywine Hospital in Coatesville, 
Pennsylvania. Full-time Emergency Medicine faculty at 
Jefferson since 1992. A variety of leadership roles in the 
medical school over the last 18 years. I am a Jefferson 
lifer with no plans to leave.
Why am I still here? Mostly, it is the friendly environment 
over the last 37 years. While there has been much 
change—we are now a 10-college, 14-hospital 
enterprise—the friendliness is the constant. The mission 
of the medical school—to train clinicians to provide 
the best patient care—remains unchanged (and is near 
and dear to my heart). I’ve seen my classmates, and 
succeeding medical school classes since, transform 
from eager students into outstanding clinicians and 
create the most welcoming educational and patient 
care environment possible. I have been fortunate 
to have watched my oldest son (class of 2021) get a 
great education in the new JeffMD curriculum. Just as 
importantly, I watch as he forms the special bonds with 
his classmates that will remain with him for his lifetime.
By virtue of my work, I am part of the Jefferson present. 
I’ve greatly enjoyed my role as the class of 1986 agent 
as it keeps me connected to the past (and my past 
keeps growing as the years pass by!). Hearing tidbits 
of information from my classmates, whether it be 
professional or personal accomplishments, always 
makes my day and brings me back to my Jefferson past.  
Keeping our class together (even if it is virtual) has been 
one of my most rewarding activities as we share a bond 
in becoming doctors. It is truly special.
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‘44
James “Jim” Geyer Dickensheets, 
99, of Hilton Head Island, South 
Carolina, died August 11, 2019. 
Raised in Gloucester, New Jersey, he 
attended Gettysburg College, then 
Jefferson, where he was a member 
of the Samuel Gross Surgical Society 
and Alpha Kappa Kappa fraternity. 
Jim completed an internship at 
Cooper University Hospital, Camden, 
New Jersey, and served in the U.S. 
Army Medical Corps with duties 
at Camp Butner Army base and 
Fort Dix. In 1954, he completed a 
residency in internal medicine at 
Jefferson Medical College and also 
did additional training in pulmonary 
medicine at the University of 
Pennsylvania, where he worked 
with Harold Israel, MD. Jim worked 
in a private practice in internal and 
pulmonary medicine at Cooper 
University Hospital, moving to Hilton 
Head Island with wife, Lois, in 1973. 
There he was instrumental in the 
opening of Hilton Head Hospital in 
1975 and maintained a busy practice 
there until his retirement at the age 
of 72. 
Jim had a great love for the practice 
of medicine and was devoted to 
his patients. He was always proud 
of his associations with Jefferson, 
both from his training years and 
through a faculty position teaching 
Jefferson medical students at 
Cooper University Hospital. He 
often recounted his training and 
ongoing working relationships with 
medicine chairs Dr. Hobart Reimann 
and Dr. John Dietrick, with whom 
he maintained a friendship for many 
years. His retirement years included 
golf, the beach, gardening, and 
playing bridge, which he enjoyed 
until his final days. 
Jim is survived by his daughter, 
Lynn, and sons James Jr., Robert, 
and David, as well as many 
grandchildren. He was predeceased 
by his wife, Lois.   
Harold Wilf, a native and longtime 
resident of Philadelphia, died on 
December 8, 2018, at the age of 
99. He received his undergraduate 
degree from the University of 
Pennsylvania and attended Jefferson 
in uniform as part of the Army 
Specialized Training Program. Upon 
graduation, Harold received both 
his degree and a commission as a 
first lieutenant in the Army. While 
at Jefferson he was a member and 
president of the Phi Delta Epsilon 
fraternity. He did his internship at 
the Philadelphia General Hospital 
and was chief resident at Northeast 
Hospital, before serving as a 
transport surgeon in the South 
Pacific, sailing to Okinawa. 
After the war, in addition to having a 
practice in the Brewerytown section 
of Philadelphia, he trained in the 
much sought-after program at the 
graduate school of medicine at the 
University of Pennsylvania, focusing 
on ENT. He later took externships 
with Matthew Ersner at Temple 
University and at the Lempert 
Institute of Otology in New York City. 
Having specialized in ENT, 
Harold at one time was on staff 
and operating at many of the 
hospitals in Philadelphia, including 
Children’s Hospital of Philadelphia, 
St. Christopher’s Hospital for 
Children, and Temple, performing 
tonsillectomies on a generation 
of children. Eventually settling his 
practice in Northeast Philadelphia, 
he became chief of ENT at 
Einstein Northern and on staff at 
Jeanes and Rolling Hill Hospitals. 
Harold performed countless 
stapedectomies and rhinoplasties, 
ultimately naming his boat “The 
Stapes.” Retiring at the age of 72, he 
spent his remaining years with his 
extended family and playing golf. 
He was preceded in death by his 
son, Edward, and is survived by his 
wife of 67 years, Constance, and 




Sonia Schorr Sloan, 91, scientist, 
political activist, fundraiser, and 
first woman graduate of Jefferson 
Medical College, died October 19, 
2019.
On June 9, 1950, Sonia made 
history when she stood among 
152 male graduates of Jefferson 
Medical College to accept her 
master’s degree in bacteriology. A 
month later, she began her career 
as an instructor at Temple Medical 
School and assistant in its new virus 
diagnostic laboratory. Two years 
after that, she became the first 
woman hired to work in DuPont’s 
Central Research Laboratory. After 
seven years at DuPont, she left 
to become a stay-at-home mom 
when her first son was born. 
Sonia worked tirelessly to improve 
the lives of others, helping to 
establish organizations such as 
the Wellness Community (now 
Cancer Support Community of 
Delaware), Public Allies Delaware, 
Agenda for Delaware Women, 
and the American Civil Liberties 
Union of Delaware. As a volunteer 
and professional fundraiser, Sonia 
brought in approximately $100 
million for organizations including 
the Food Bank of Delaware, the 
Delaware College of Art and Design, 
and the West End Neighborhood 
House. She also served as 
president of the board for Planned 
Parenthood of Delaware. 
Sonia is a member of the Hall of 
Fame of Delaware Women, and 
was recognized with the state of 
Delaware’s highest honor, the Order 
of the First State. 
In April 2019, she received the 
Jefferson College of Life Sciences’ 
Alumni Lifetime Achievement 
Award. She was the first student—
male or female—to earn a degree 
from the graduate program that 
eventually became the College of 
Life Sciences.
Sonia, a lifelong Democratic activist, 
was a close friend to former Vice 
President Joe Biden, working on 
every one of his campaigns since 
1970. 
Sonia is survived by her husband 
of more than six decades, Gilbert; 
two sons; five granddaughters; and 
three great-grandchildren.
’52
Arthur N. Avella, noted psychiatrist 
and former hospital director, died 
on Jan. 30, 2019. Born June 20, 
1923, in Manville, New Jersey, to 
Rose and Paul Avella, Arthur served 
in the U.S. Navy in the Pacific 
theater during World War II and 
retired from the Naval Reserve as a 
lieutenant.
He received his BA from Oberlin 
College and his MD from Jefferson 
Medical College, now Sidney 
Kimmel Medical College. He 
interned at Muhlenberg Regional 
Medical Center in Plainfield, New 
Jersey, and St. Joseph Hospital in 
Philadelphia. He was a resident in 
psychiatry at the Menninger School 
of Psychiatry in Topeka, Kansas, 
and the Roosevelt Hospital (later 
Mount Sinai St. Luke’s hospital) in 
Manhattan. His post residencies 
included the Roosevelt Hospital 
(fellow in psychiatry), the William 
Alanson White Institute, and Harvard 
University’s program for health 
systems management.
From 1953 to 1957, he had a general 
practice in Westfield, New Jersey. 
In 1960, he joined Robert Laidlaw, 
MD, in a psychiatric practice 
and, eventually, opened his own 
private practice in psychiatry and 
psychoanalysis in Manhattan in 
1969. During this period, he was 
also director of clinical services 
and assistant clinical director and 
education coordinator at Roosevelt 
Hospital. Subsequently, he became 
the director of residency training 
at Manhattan Psychiatric Center. 
In 1980, Arthur returned to New 
Jersey to become medical director 
at the Essex County Hospital 
Center until 1986, when he became 
hospital director. He retired in 1991.
Always the academic, he was a 
clinical associate professor of 
psychiatry at NYU Medical Center 
(now NYU Langone Health), 
assistant clinical professor and 
associate in psychiatry at Columbia 
University’s College of Physicians 
and Surgeons (now Vagelos College 
of Physicians and Surgeons), and 
clinical assistant professor at the 
University of Medicine and Dentistry 
of New Jersey.
In retirement, Arthur never lost 
his love of learning. He was a 
student of comparative religions, 
the Italian Renaissance, music 
history, opera, and philosophy. He 
traveled extensively and was an 
avid concertgoer and theatergoer. 
He also had a keen interest in the 
piano, playing frequently for family 
and friends.
Between 1993 and 2013, he 
maintained a winter residence 
in West Palm Beach, Florida. He 
moved to Crane’s Mill retirement 
community in West Caldwell, New 
Jersey, in 2005.
Arthur was predeceased by 
his sisters, Nina, Mildred, and 
Antoinette, and by his brothers, 
Nathaniel and Joseph. Those who 
mourn his passing include his 
nieces, nephews, great-nephews, 
and special friends Bill Hagel, 
George Bales, and Dr. Susan 
(Skalsky) Bales. He will be especially 
remembered for his quick wit, spirit 
of adventure, and the tenaciousness 
that allowed him to achieve top 
rankings in many diverse endeavors.
’54
Edward Tober, 90, of Exeter, 
New Hampshire, died on May 20, 
2019. Born February 12, 1929, in 
Portsmouth, New Hampshire, 
Edward graduated from Harvard 
University before attending 
Jefferson Medical College. While 
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at Jefferson, he was a member 
of the student council and Kappa 
Beta Phi fraternity, and maintained 
a junior internship at the Episcopal 
Hospital of Philadelphia. Following 
a one-year internship at Mount Sinai 
Hospital in New York, Edward served 
two years in the United States Navy. 
He practiced general and thoracic 
surgery in Lowell, Massachusetts, 
for 30 years. He was a dedicated 
physician who enjoyed spending 
time with his patients.
After retirement, Edward attended 
grand rounds with the surgeons 
at Dartmouth-Hitchcock Medical 
Center in New Hampshire to discuss 
cases and to keep his hand in 
medicine. The rest of his retirement 
time was spent attending opera, 
ballet, concerts, and the symphony 
with his wife of almost 58 years, 
Linda, and devoting time to his five 
adoring grandchildren.    
Some of Edward’s fondest memories 
were of his time at Jefferson. He and 
Linda regularly attended reunions to 
reconnect with classmates.
Aside from his wife and 
grandchildren, Edward is survived by 
two children.
’56
Jean Mountain Miller, 85, died 
on March 8, 2019, in Cleona, 
Pennsylvania. Jean received 
her BS from Wooster College 
before coming to Jefferson. She 
graduated with a diploma in medical 
technology from Jefferson Medical 
College in 1956. While there, she 
met her husband, Claude J. Miller, 
MD ’59. Jean’s father, Dr. Walter 
Scott Mountain, was a 1926 graduate 
of Jefferson and practiced in 
Gettysburg.
Upon graduation from Jefferson, 
Jean gained employment at 
Graduate Hospital in Philadelphia 
and assisted Dr. Bazar in directing 
the work of the laboratory there. She 
often mentioned how grateful she 
was for all the excellent training she 
received at Jefferson, especially from 
Dr. Carlos Aponte.
Apart from her love of her work as 
a medical technologist, Jean was 
involved in every facet of church life 
at St. Andrews Presbyterian Church 
in Lebanon, Pennsylvania, for more 
than 50 years, including singing in 
the choir.
Jean is survived by her husband, 
Claude; her two daughters, Julie 
Kramer and Karen Anderson; seven 
grandchildren; and one great-
grandchild.
’66
Henry H. Hood died at his home 
on May 31, 2019. Born on June 30, 
1939, in Washington, Pennsylvania, 
Henry received his high school 
diploma from Millbrook School in 
Millbrook, New York. After receiving 
an undergraduate degree from 
Brown University in 1961, he spent 
a year at Washington & Jefferson 
College in preparation for medical 
school at Jefferson Medical College 
in Philadelphia, where he graduated 
in 1966. Prior to moving to Lancaster, 
Pennsylvania, in 1974 to open a 
private practice, he completed 
residencies in Akron, Ohio, Chicago, 
and Toronto; served two years in 
the Air Force at the Minot Air Force 
Base Regional Medical Hospital; and 
taught at the University of Florida 
College of Medicine. 
Henry was passionate about 
teaching and mentoring. Throughout 
his career in private practice, he 
welcomed numerous medical 
students into his office who would 
spend months learning new skills. 
For 18 years, he spent Sunday 
mornings at the New Life Church in 
Columbus, Ohio, offering medical 
services to the homeless and 
destitute, while simultaneously 
mentoring medical students from 
Ohio State University’s College of 
Medicine who volunteered at the 
clinic. He also started a free medical 
clinic for local residents at Maywood 
Mission. 
In 1984, Henry met Dr. Robert 
Simon, founder and chairman of the 
board of the International Medical 
Corps (IMC), and a lifelong friendship 
and partnership was born. For 35 
years the two worked to build the 
IMC into an organization which has 
provided medical relief, education, 
and training to 51 countries around 
the globe. Through IMC, Henry 
worked in a number of war zones, 
including Afghanistan, Somalia, 
Nicaragua, Pakistan, and disaster 
areas such as Haiti and Indonesia, 
helping to train doctors and medic 
trainees in vital surgical skills. To train 
Afghan medics he invented a traction 
device made of bamboo shoots 
and ties that remains in the manual 
he helped write 30 years later. The 
reduction of common dislocations 
was taught using techniques he 
invented, such as using a tree limb 
and lever system he developed to 
reduce complex dislocations and 
fracture dislocations. In addition to 
being a founding board member 
of IMC, Henry was the chair of its 
international operations committee.
Henry is survived by his wife, 
Eleanor Hood; his son, Henry H. 
Hood III, and his family, including 
wife Diane Hood, children Garrett 
and Meredith, and stepchildren 
Chasity and Jennifer; his daughter, 
Elise Hood Egan, and her family, 
including husband Michael J. Egan 
and children Michael “Jay,” Halie, and 
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Annabel; his brother, Paul B., and his 
wife, Molly Hood; and his loving cat, 
Jasper.
Richard A. Ulrich died on October 
17, 2019, after a long battle with 
heart disease. Born on May 25, 1941, 
in Norfolk, Nebraska, he grew up 
on a 160-acre farm with his twin 
brother and younger sister. Richard 
completed a BS at Houghton 
College, an MD at Jefferson 
Medical College (now SKMC), and 
an internship at Geisinger Medical 
Center. He joined the Air Force as a 
flight medical officer and served as 
the only doctor at Kimpo Air Base, 
South Korea, from 1967 to 1968. He 
then transferred to McCoy Air Force 
Base, where he married Angelia 
Sue Carthen. Richard trained in 
ophthalmology at the University of 
Iowa and served at Maxwell Air Force 
Base and as chief of hospital services 
at Offutt Air Force Base. He retired 
as a colonel and moved to Georgia 
in 1987, where he worked with Dr. J. 
L. Gayton and Dr. M. Gary Carter in 
Warner Robins.
Richard is survived by his wife, 
Angelia Ulrich, and their four sons 
and families: Dr. Lane Ulrich, MD, his 
wife, Debra, and children Lydia, Colin, 
Elise, and Celia; Dr. Marc Ulrich, PhD, 
his wife, Rebecca, and children Karis, 
Stephen, Andrew, Timothy, Joshua, 
Samuel, and Addy; Dr. Paul Ulrich, 
PhD, his wife, Rachel, and children 
Annalise and Lauren; and Dr. Luke 
Ulrich, PhD, his wife, Megan, and 
children Caleb, Eli, and Seth. He is 
also survived by his twin brother, Dr. 
Wesley Ulrich, MD, and his sister, Mrs. 
Mary Ulrich Gustafson.
Those who knew Richard are likely 
to remember his avid interest in the 
Bible, family, Shirley Hills Baptist 
Church, medicine, music, science, 
tinkering, Gansu Inc., the Gideons, 
Christian Medical Dental Association, 
history, and computers. His motto 
was “Just do it God’s way.” He was 
utterly grateful for life with God, 
family, friends, and patients.
’79
Noah Allan Babins died on June 29, 
2018. He was born November 2, 
1956, in Philadelphia, Pennsylvania, 
to Louis and Joan Babins. Noah was 
a brilliant student who was accepted 
during high school to the medical 
school bridge program at Penn State 
University and Jefferson Medical 
College (now SKMC). This allowed 
him to become a medical doctor at 
the age of 22.
In 1985 Noah moved to Orlando, 
Florida, where he met the love of 
his life, Kary Alger Babins. They 
married in 1987. Shortly after, 
they moved to Bowling Green, 
Kentucky, where Noah established 
his own anesthesiology practice. 
In 1989 the family moved back to 
Orlando, where Noah worked as an 
anesthesiologist at Orlando Health 
until the time of his passing. Noah 
was a mentor to many and a friend 
to most, always willing to take time 
to provide thoughtful advice or 
guidance.
Noah was an avid fisherman and a 
world traveler. He loved the Bahamas 
and spent a substantial amount of 
time traveling throughout Spain and 
Spanish-speaking countries, where 
he learned the language. He was a 
lifelong Philadelphia sports fan and 
was delighted to see his Eagles win 
the 2017 Super Bowl.
Noah loved and adored his three 
children: Shanna Gatton and 
husband, Brady Gatton; Aaron Babins 
and his wife, Musy; and Jacob Babins 
and his wife, Kelli. Noah was known 
as Zaydee to twin grandchildren 
Myles and Graham Gatton. Noah 
was also survived by his mother, 
Joan Babins; sister, Irene Repka, 
and her husband, Dr. Mark Repka; 
and brother, Dr. David Babins, and 
his wife, Rhonda. He was also loved 
by so many more family members, 
including cousins, nieces, and 
nephews.
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Join Jefferson alumni 
to explore, learn, and 
experience the world!
As part of our commitment to lifelong learning, the Office of 
Alumni Relations is excited to offer Jefferson alumni a varied 
itinerary of group travel destinations that combine educational 
forums and excursions to places of historical and cultural interest, 
with the opportunity to enjoy unplanned experiences and unique 
adventures. These trips offer the highest-quality travel experience 
through our partnerships with experienced travel providers.
Visit Jefferson.edu/TravelProgram to learn more about our 
upcoming trips.
To request an individual brochure for a specific destination, 
please contact the Office of Alumni Relations at 215-955-7750.
Southwest National Parks
May 13–21, 2020
Explore the Mighty Saint Lawrence 
Seaway
June 4–16, 2020




Relics & Retreats of the Western 
Mediterranean










Let the Bulletin community 
know what you’ve been up 
to by sharing your news in 
Class Notes!
Send us your news: editor@jefferson.edu
Achievements
Events
Milestones
Accolades
